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INTEGRATION OF SINGLE-CELL ELECTROPERMEABILIZATION TOGETHER WITH 
ELECTROCHEMICAL MEASUREMENT OF QUANTAL EXOCYTOSIS ON MICROCHIPS 
 
Jaya Ghosh 
Dr. Kevin D. Gillis, Dissertation Supervisor 
ABSTRACT 
 An electrochemical microelectrode located immediately adjacent to a single 
neuroendocrine cell can record spikes of amperometric current that result from quantal 
exocytosis of oxidizable transmitter from individual vesicles. Using electroporation we 
have developed an efficient method where the same electrochemical microelectrode is 
used to electropermeabilize an adjacent chromaffin cell and then measure the consequent 
quantal catecholamine release using amperometry. Trains of voltage pulses, 5–7 V in 
amplitude and 0.1–0.2 ms in duration can reliably trigger release from cells using gold 
electrodes. Amperometric spikes induced by electropermeabilization have similar areas, 
peak heights and durations as amperometric spikes elicited by depolarizing high K+ 
solutions. Uptake of trypan blue stain into cells demonstrated that the plasma membrane 
is permeabilized by the voltage stimulus. Robust quantal release is elicited upon 
electroporation in 0 Ca2+/5 mM EGTA in the bath solution. Electropermeabilization-
induced transmitter release requires Cl- in the bath solution – bracketed experiments 
demonstrate a steep dependence of the rate of electropermeabilization-induced 
transmitter release on [Cl-] between 2 and 32 mM. Using the same electrochemical 
electrode to electroporate and record quantal release of catecholamines from an 
individual chromaffin cell allows precise timing of the stimulus, stimulation of a single 
cell at a time, and can be used to load membrane impermeant substances into a cell. 
1 
CHAPTER 1 
INTRODUCTION 
Unique chemical and biological insights at the single-cell level have been made 
possible by advances in methodology enabling chemical measurements of very small 
volumes of analytes and at small spatial dimensions with high sensitivity and selectivity. 
Using a variety of methods and platforms, small analytes such as amino acids and 
neurotransmitter molecules as well as larger proteins and cell organelles have been 
quantified in single cells. 
The use of microchip devices to study cellular systems is a research area that is 
growing at a rapid pace and poses numerous advantages. Microchip-based cellular 
analysis with electrochemistry as the basis for detection is used in a variety of systems 
including on-chip detection of quantal exocytosis from individual cells, electrochemical 
analysis of intracellular contents, use of integrated electrodes to assay cell confluency, etc 
… (Sims and others 2007; Ge and others 2010; Cans and others 2011; Johnson and others 
2013). With the new appreciation of cellular heterogeneity in terms of variability in 
genetic composition, biochemistry, and physiology, traditional assays which yield data 
averaged across large groups of cells are being replaced by individual cell studies. 
Factors like variation in expression of genes, proteins and metabolites have been found to 
elucidate unique biological phenomena in single cells that are not detectable by bulk 
sampling procedures. 
Technical specifications for single cell analysis are strict but various bioanalytical 
techniques have been developed to measure individual quantal neurotransmitter secretion 
2 
events at the single cell level (Wightman and others 1991; Chow and others 1992; De 
Toledo and others 1993; Chen and others 1994; Chen and others 1995; Finnegan and 
others 1996; Albillos and others 1997; Hochstetler and others 2000; Pothos 2002; Staal 
and others 2004; Zhang and others 2009). Studies reporting the use of carbon-fiber based 
microelectrochemical methods for measurement of neurotransmitters were reported as 
early as the late 1970s (Gonon and others 1978; Ponchon and others 1979). In the early 
1990s, Wightman and coworkers (Leszczyszyn and others 1990; Kawagoe and others 
1991) were the first to use carbon-fiber-based electrochemical methods for single-cell 
exocytosis studies. Adrenal glands of cattle and rats provided the first model secretory 
cells for electrochemical detection of quantal exocytosis because not only did they 
contain secretory vesicles that store catecholamines, but also because of their 
neuroectodermal origin and biochemical and functional similarities with true sympathetic 
neurons. In fact, compared to neurons, nonsynaptic cell models like the chromaffin cells 
are preferred for studying single-cell exocytosis because the release site on the 
neuroendocrine cell is easily accessible to the electrochemical microelectrodes. 
Single cell electrochemical measurements have been done in primary as well as 
cell lines. Examples include catecholamine release from adrenal medullar chromaffin 
cells (Pihel and others 1996) and rat PC12 (pheocromocytoma) cells (Chen and others 
1994), 5-hydroxytryptamine and histamine from mouse mast cells (Marszalek and others 
1997), insulin from pancreatic β-cells (Barnett and others 1996), and metabolic molecules 
such as nitric oxide and hydrogen peroxide from single cells (Amatore and others 2008). 
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1.1 Exocytosis 
Exocytosis is an essential vesicle trafficking process. It is the means by which 
cells direct intracellular vesicles to fuse with the plasma membrane and release their 
contents to the extracellular space, or, incorporate newly synthesized membrane proteins 
into the plasma membrane. Two types of exocytosis are seen in eukaryotic cells – non-
Ca2+-triggered constitutive exocytosis, and regulated exocytosis (Kelly 1985). In 
constitutive exocytosis, transport vesicles fuse with the plasma membrane constitutively 
to release their contents and no external stimulus is needed to trigger exocytosis by 
altering the level of a cytoplasmic second messenger. It is seen in all eukaryotic cells and 
is used to deliver newly synthesized proteins to the cell membrane and extracellular 
environment (Palade 1975; Schmoranzer and others 2000). Regulated exocytosis, on the 
other hand, is triggered by extracellular or intracellular signals such as cytoplasmic 
messengers including Ca2+, cAMP, cGMP, etc. Ca2+-dependent exocytosis is a process by 
which discrete vesicles fuse with the cell membrane and release their contents into the 
extracellular environment in response to an increase in intracellular Ca2+ concentration 
[Ca2+]i. Most neurons and neuroendocrine cells secrete hormones and neurotransmitters 
via Ca2+-dependent exocytosis in response to Ca2+ influx as voltage-gated Ca2+ channels 
are opened by membrane depolarization. 
By initiating secretion of neurotransmitters and hormones, Ca2+-triggered 
exocytosis plays a fundamental role in cell-to-cell communication. On application of an 
appropriate stimulus, the vesicles fuse to the cell membrane and release their contents in 
order to trigger various responses in the target cell or environment. It is important to 
study the exocytosis mechanism in details as it plays an important role in various regular 
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neurological functions as well as in disease conditions. Parkinson’s disease is a 
degenerative disorder of the central nervous system, which is characterized by symptoms 
like tremors, slowed movement, rigid muscles, impaired posture and balance, and is 
caused by the loss of dopaminergic neurons of the substanitia nigra in the brain and the 
resultant loss of dopamine release from neurons. L-3,4-dihydroxyphenylalanine (a.k.a. L-
dopa or Levodopa), the precursor of dopamine, provides symptomatic relief for 
Parkinson’s disease by increasing the amount of dopamine packaged into individual 
vesicles (Pothos and others 1996; Pothos and others 1998; Sulzer and others 2000; Pothos 
2002; Gong and others 2003). In Huntington’s disease, a neurodegenerative genetic 
disorder that typically becomes noticeable in mid-adult life, the amount of catecholamine 
secretion from each vesicle is diminished significantly although the number of secretion 
events remains the same. This affects muscle coordination and leads to cognitive decline 
and psychiatric problems in patients (Johnson and others 2007).  
SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein 
REceptor) proteins are a large family of proteins that play a primary role in vesicle fusion 
(Sudhof 1995; Neher 1998; Burgoyne and others 2003; Sørensen 2005; Jahn and others 
2006; Jahn and others 2012). The synaptic proteins synaptobrevin, syntaxin 1 and SNAP-
25 belong to the SNARE protein family. Clostridial neurotoxins, such as Botulinum 
Toxin types A and E (BoNT/A and BoNT/E), can inhibit the process of exocytosis and 
cause muscle paralysis and even death. Whereas effects of the neurotoxin can be lethal, 
local applications in very low doses can be helpful in treating various medical conditions. 
BoNT/A is best known for its use in cosmetic treatment (BOTOX®) whereby it 
temporarily improves the appearance of frown lines between the eyebrows and is also 
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used for treatment of uncontrollable movement disorders. The underlying working 
principle is that the toxin selectively blocks exocytosis of acetylcholine at a 
neuromuscular junction by cleavage of the SNARE protein SNAP-25, thus inhibiting 
acetylcholine-containing vesicle fusion with the cell membrane. By inhibiting 
acetylcholine release, the toxin causes flaccid paralysis of muscles, which can 
temporarily “relax” frown lines (Song 1998; Frampton and others 2003; Said and others 
2003). BoNT toxin products are also used for treating excessive underarm sweating, 
migraine and other primary headache disorders, certain neurological disorders such as 
spasticity, and muscle pain disorders including cervical dystonia, eyelid spasms and 
crossed eyes (Boghen 1996; Kreyden and others 2000; McNeer and others 2000; 
Connolly and others 2003; Blumenfeld and others 2004). 
Regulated exocytosis is highly conserved across several cell types including 
neurons, adrenal chromaffin cells, PC12 cell line (which is derived from a 
pheochromocytoma of the rat adrenal medulla), insulin-secreting pancreatic β-cells, 
platelets and a variety of immune cells such as mast cells and macrophages (Burgoyne 
and others 2003; Kim and others 2011). Our study focuses on chromaffin cells which are 
found mostly in the medulla of the adrenal glands. They secrete catecholamines 
(primarily epinephrine / adrenaline and some norepinephrine / noradrenaline), dopamine 
and a few other hormones (Fenwick and others 1978). The secreted adrenaline and 
noradrenaline play an important role in the fight-or-flight response whereby they directly 
increase heart rate, trigger the release of glucose from energy stores, and increase blood 
flow to skeletal muscle. Norepinephrine and dopamine act as neuromodulators in the 
central nervous system and hormones in blood circulation. 
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The biophysical and biochemical properties of exocytosis have been extensively 
studied but the detailed molecular mechanism and kinetics of exocytosis still continue to 
be challenging topics. Several powerful techniques with high sensitivity, signal-to-noise 
ratio and spatio-temporal resolution have emerged to help advance our understanding of 
this fundamental mode of intercellular communication. Platforms like carbon-fiber 
microelectrodes (CFEs) have been commonly used to study quantal exocytosis of 
electroactive transmitters such as catecholamines from individual cells (Wightman and 
others 1991). Though it is a robust technique, it is a low-throughput process involving 
manual positioning of an electrode adjacent to an individual cell surface using 
micromanipulators while observing the preparation under a microscope. Experiments are 
performed on one cell at a time and the carbon fiber electrodes have to be manually 
fabricated in small lots and need to be cut to expose a fresh surface or replaced 
frequently. Recently, in an effort to enable high-throughput experiments, microfabricated 
lab-on-a-chip devices have been developed with arrays of microelectrodes where cells 
can be targeted to individual electrodes thereby eliminating the need to manually bring 
electrodes to cells.  
A common technique used to stimulate exocytosis is perfusion of cells with a 
secratogogue leading to depolarization of the cell membrane, opening of voltage-gated 
Ca2+-channels, Ca2+ influx and Ca2+-triggered release of neurotransmitter that is 
measured by on-chip electrochemical microelectrodes at the single-cell and single-vesicle 
level. Perfusion systems however, usually stimulate multiple cells and do not allow the 
stimulation to be timed precisely. In order to address these limitations, we have 
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developed an electrical stimulation approach that is integrated together with 
electrochemical measurement of quantal exocytosis on microchips. 
1.2 Detection of exocytosis 
Since individual secretory vesicles are small in size (25-500 nm), and the release 
event occurs in the milliseconds range, measurement of quantal exocytosis requires 
sensitive techniques of chemical analysis with high signal-to-noise ratios and high spatio-
temporal resolution (Travis and others 1998). Commonly used techniques for exocytosis 
measurement include patch clamp, amperometry, and voltammetry. 
Patch clamp is a powerful technique that allows electrophysiological study of 
single or multiple ion channels in cells. The technique can be applied to a wide variety of 
cells, but is especially useful in the study of excitable cells such as neurons, 
cardiomyocytes, and pancreatic beta cells. Erwin Neher and Bert Sakmann developed this 
technique (Neher and others 1976) in the late 1970s and early 1980s. This technique 
made it possible to record currents of single ion channels for the first time, and for their 
pioneering work, Neher and Sakmann received the Nobel Prize in Physiology and 
Medicine in 1991. 
The basic working principle of patch clamp consists of using a glass micropipette 
with a very small open tip diameter to attach to a patch of cell membrane and record 
electrical activities going on in that patch or the whole cell (as shown in Fig 1.1). The 
patch pipette tip has a diameter of ~1 µm and is maneuvered to press gently against a cell. 
Suction is slowly applied to the inside of the pipette to pull a small patch of the cell 
membrane into the pipette tip. The patch and the pipette can form a tight seal with an 
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electrical resistance of over 1 GΩ, (hence it is called a gigaseal). The high resistance of 
this seal makes it possible to electrically isolate and measure with high signal-to-noise 
ratio the small currents (in the picoamp (10-12 A) range) generated due to ion flow 
through individual channels in the patch. The Food and Drug Administration uses this 
technique as the gold standard screening process for studying the interactions between 
drugs and ion channels during new drug discovery research. This is known as the cell-
attached or on-cell patch configuration. 
 
Fig 1.1 A schematic showing a single ion channel being recorded within the patch pipette 
Several variations of the basic technique allow different modes of recording the 
electrical activity of the whole cell or the channels in the patch of membrane forming the 
seal. In the whole-cell patch clamp mode, the patch is ruptured by application of sudden 
suction pulses, and this allows recording of current throughout the whole cell. Also via 
diffusion, the intracellular solution can be exchanged for the solution contained in the 
glass pipette. In this study, we mainly employed whole-cell patch clamp recording in 
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order to measure action potentials as well as exocytosis-induced changes in membrane-
area. 
Action potentials are the physiological stimuli for secretion of hormones and 
neurotransmitters from most neurons and neuroendocrine cells. In neurotransmitter-
secreting cells, Ca2+-triggered exocytosis is known to be induced by action potentials 
(shown in flow-chart below) which can be triggered in cells using external stimuli. 
 
One widely used approach that is employed in neuroscience is to trigger an action 
potential using a transient electric field produced by a pair of extracellular electrodes.  
 
Fig 1.2 Equivalent circuit of a cell in the whole-cell patch clamp configuration 
Action 
potentials
Voltage-
dependent 
Ca2+ channels 
open
Ca2+ influx Ca
2+-triggered 
exocytosis
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The capacitance of a cell membrane is proportional to its area. Upon fusion of 
vesicles, exocytosis leads to an increase in the cell membrane area, which in turn results 
in an increase in the measured capacitance. The whole-cell patch clamp technique can 
also be used to measure membrane capacitance changes and the equivalent circuit of a 
patch clamped cell in whole-cell mode is shown in Fig 1.2. The lipid bilayer of a cell 
membrane can be simplified as a membrane resistor (Rm) and a membrane capacitor (Cm) 
together with a cell resting potential (EREV). The pipette electrode has series resistance 
(RA). By applying a sinusoidal voltage (VP) to the glass pipette electrode and measuring 
the current (IP), membrane capacitance can be calculated using complex impedance 
analysis of the equivalent circuit (Gillis 1995; Marty and others 1995). Endocytosis, as 
opposed to exocytosis, leads to capacitance decreases due to membrane retrieval. With 
millisecond time resolution, cell membrane capacitance measurements provide detailed 
information about the time course of vesicle fusion. Though this method can help in 
understanding fusion pores dynamics, it does not directly measure release of 
neurotransmitter. For example, fusion of an empty vesicle produces similar capacitance 
changes to that of a transmitter-laden vesicle. A membrane capacitance change could also 
be induced by other membrane processes (Borges and others 2008) – some studies show 
that recovery of Na+ channel from inactivation also accounts for non-exocytotic sources 
of capacitance change (Horrigan and others 1994). 
In the 1950s, Sir Bernard Katz and colleagues pioneered the study of exocytosis at 
neuromuscular junction of frogs by recording the miniature endplate potentials generated 
by the release of acetylcholine molecules (Fatt and others 1950; Fatt and others 1950; 
Fatt and others 1952). These experiments led to the “quantal” hypothesis which states 
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that transmitter is released in discrete packets, now understood to be vesicles. However, it 
was only after the development of amperometry 40 years later that quantal release of 
neurotransmitter via exocytosis was directly measured. The Adams group was the first to 
work on the basic principles of monoamine oxidation at the electrode surface (Kissinger 
and others 1973; McCreery and others 1974). Following their work, Wightman’s group 
(Leszczyszyn and others 1990; Chow and others 1992; Travis and others 1998) and 
others (Chow and others 1992) employed carbon fiber electrodes (CFEs) to detect quantal 
secretion of catecholamine from single vesicles of chromaffin cells. Potentially detectable 
chemicals include adrenaline, noradrenaline, dopamine, histamine and serotonin. Carbon 
fiber electrodes are mechanically rigid, chemically stable and highly conductive (Schulte 
and others 1996) making them the ideal candidate for electrodes used to measure quantal 
exocytosis. Released neurotransmitters are readily oxidized, and therefore can be detected 
using electrochemical techniques. 
 
Fig 1.3 Illustration of carbon fiber amperometry in single cell quantal exocytosis measurement. 
Reprinted by permission from Macmillan Publishers Ltd: Nature Methods, (Evanko 2005), 
copyright 2005 
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Amperometry is the measurement of faradaic current while the measuring 
electrode potential is held at a constant value. This method allows the measurement of 
analyte with high time resolution but the identity and concentration of the analyte cannot 
be resolved. By holding a carbon fiber electrode at the constant potential (typically 600 – 
700 mV), which far exceeds the redox potential of the released transmitter, a current can 
be recorded and the number of electroactive molecules along with the frequency of 
release can be known. In the oxidation process, each catecholamine molecule loses two 
electrons to the electrode and each spike in current represents a single-vesicle fusion 
event. The transmitter release process consists of multiple steps including fusion pore 
formation, fusion pore expansion and full fusion or closure of pore, which are evidenced 
by the foot signal, the steep rising phase of the amperometric spike and the slower 
exponential fall, respectively (as shown in Fig 1.3). Integration of the amperometric 
current indicates the amount of transmitter released from an individual vesicle. The time 
course of the spike provides important information about vesicle fusion event and release 
kinetics. With amperometry, millisecond time resolution and sensitivity of few tens of 
thousands of molecules can be achieved (Bruns and others 1995) if careful noise 
shielding and filtering are applied. Similarly, a foot signal (Chow and others 1992), 
provides information on the fusion pore geometry and its lifetime. It reflects the slow 
release of transmitter through a ~2 nm fusion pore before dilation of the pore leads to 
rapid release indicated by amperometric spikes (Alvarez De Toledo 1995; Lindau and 
others 2003). 
As further demonstrated in Fig 1.4, important parameters can be extracted from 
recorded amperometric spikes. The maximum oxidation current, Imax, is the maximum 
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flux of neurotransmitters released during a vesicle fusion. Half-width t1/2, is determined at 
50% of Imax and describes how fast the molecules are released from the vesicle, and Q, 
the total charge, represents the area under the spike which can be used to calculate the 
total number of electroactive molecules released during a vesicle fusion event (Fig 
1.4(a)). tfoot is an empirical measurement of the lifetime of the pore, Qfoot, the charge 
under the foot signal, can be used to calculate the number of molecules released through 
the pore, and Ifoot describes the flux of neurotransmitter released during the duration of 
the foot signal. Fig 1.4(b) shows parameters of a typical pre-spike foot signal.  
 
Fig 1.4 Relevant quantitative and kinetic parameters of an amperometric spike. (a) Imax, t1/2 and Q. 
(b) Foot signal with Qfoot, tfoot and Ifoot. Reprinted by permission from Macmillan Publishers Ltd: 
Nature Methods, (Mosharov and others 2005), copyright 2005 
Patch amperometry (Albillos and others 1997) is a combination of patch clamp 
and carbon fiber amperometry techniques. Simultaneous measurement of membrane 
fusion capacitance and amperometric current from neurotransmitter oxidation was 
achieved by a novel technique that incorporated a carbon fiber microelectrode inside a 
traditional patch clamp pipette. Using the patch amperometry method, it is possible to 
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distinguish transient and full fusion events, and to analyze individual fusion pore 
openings and the role of the fusion pore in limiting release (Dernick and others 2003). 
The methods described above have high sensitivity and spatial resolution but they 
have one disadvantage that is common to all of them. They require the manual 
positioning of the detecting microelectrode or patch pipette against an individual cell 
making the process labor intensive and low throughput. In addition, it is difficult to image 
the release site of the cell that is directly adjacent to the carbon fiber. 
1.3 BioMEMS and on-chip amperometry 
Micro-Electro-Mechanical Systems (MEMS), initiated in the 1970s, is a 
technology that uses miniaturized mechanical and electro-mechanical elements. These 
structures or devices are made using microfabrication techniques that were adapted from 
the semiconductor industry. As of 2002, the commercial market size of MEMS was over 
trillions of dollars (Madou 2002). MEMS devices have a number of relative advantages 
including batch fabrication at significantly reduced costs per unit. They can either be 
reusable or disposable making them ideal for different types of applications. MEMS 
devices are developed for a variety of platforms including mechanical, electrical, 
chemical as well as biological. Some popular examples of MEMS-devices are: silicon 
microphones (sound/voice sensor), gyroscopes, accelerometers (motion/position sensors), 
pressure-sensors, micromirrors (light actuator), Oscillators/Resonators, FR-MEMS 
switches (RF actuators), Ink-jet MEMS modules, Microfluidics & Bio-chips (Fluid 
actuators) and various other devices used in displays, IR sensing, fiber optics connectors, 
drug delivery systems, immunosensors, DNA arrays, etc. Medical and biomedical 
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application of MEMS reached over ten billion dollars in 2004 (Madou 2002) and 
Biomedical or Biological Micro-Electro-Mechanical Systems (BioMEMS) are now a 
heavily researched area with a variety of important applications to boast of. Areas of 
research and applications in BioMEMS range from diagnostics (DNA and protein 
microarrays), to various types of sensors, novel materials and biomaterials, microfluidics, 
tissue engineering, surface modification, implantable devices, and drug delivery systems 
(Bashir 2004). Some important commercial products include drug delivery patches from 
Cygnus Glucowatch, hand-held blood analyzers, on-line pressure monitoring from 
Motorola and Siemens, neural stimulating probes from the University of Michigan, 
pacemakers, and molecular diagnostic testing platforms like the Nanogen NanoChipTM 
(Madou 2002). 
As with various other biological applications, microfabrication techniques are also 
being used by researchers to develop microchip platforms for single-cell 
electrophysiological (patch clamp on chip) and electrochemical (amperometry on chip) 
measurements. Over the last decade various designs in the form of planar or lateral patch 
clamp on a chip device have been implemented. Materials ranging from silicon, to 
quartz/glass, polyimide, Teflon, and PDMS have been used to fabricate these patch clamp 
devices. Integration with microfluidics has introduced functionalities and automation 
modules in patch clamp measurements. Some of the popular approaches used include 
small apertures in silicon nitride covered by silicon dioxide followed by chemical 
modification (Schmidt and others 2000), deposition of a plasma-enhanced chemical 
vapor deposition (PECVD) oxide film to narrow down the aperture and increase its depth 
(Sordel and others 2006), hydrophobic pores in silicon dioxide (Pantoja and others 2004), 
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hollow SiO2 nozzles protruding out of plane and embedded in larger cavities to emulate 
the 3D profile of a patch pipette tip (Lehnert and others 2002), etching small apertures on 
pre-thinned fused quartz or borosilicate glass to enable formation of gigaseals (Fertig and 
others 2001; Fertig and others 2002; Fertig and others 2002; Fertig and others 2003), 
round patch apertures on a polyimide film milled by a focused ion beam and etched by O2 
plasma through a resist pattern (Stett and others 2003), apertures fabricated in amorphous 
Teflon (Teflon AF) sheets (Mayer and others 2003), and small apertures in PDMS 
(Klemic and others 2002). Some of these approaches result in high gigaseal success rates 
and while some offer medium throughput but high-quality recordings, others are 
relatively high throughput systems with only modest seals. A number of companies like 
Sophion, Nanion, Cytocentrics, Molecular Devices (Ionworks and PatchXpress featuring 
the technologies from Essen Instruments and the SealChip® of Aviva Biosciences) and 
more recently Fluxion Biosciences (Yobas 2013) are involved in the manufacture of 
commercial planar patch clamp platforms. 
Planar electrochemical electrodes have also been developed. Various design 
considerations including i) different electrode materials, ii) surface modification to 
promote cell attachment, iii) assaying multiple cells using arrays of microelectrodes on-
chip, iv) cell trapping methods, v) cell targeting methods, vi) developing different 
stimulation methods, and vi) simultaneous detection of amperometry and fluorescence 
imaging or TIRF, have been studied and explored thoroughly. The different electrode 
materials that have been used are gold (Chen and others 2003; Dittami and others 2010), 
platinum (Hafez and others 2005; Berberian and others 2009), graphite electrode on Si 
substrate (Parpura 2005) Indium Tin Oxide (ITO) (Amatore and others 2006; Sun and 
17 
others 2006), Nitrogen-doped Diamond-Like-Carbon (DLC:N) (Gao and others 2008; 
Barizuddin and others 2010), and boron-doped nanocrystalline diamond (NCD) on a 
sapphire wafer (Carabelli and others 2010). Spikes recorded on different kinds of 
electrodes have been compared to see how important spike parameters and sensitivity can 
vary from one material to the other (Kisler and others 2012). Electrode surfaces have 
been modified to improve sensitivity and specificity of target analyte molecules. 
Modification of Au electrodes with mercaptopropionic acid (MPA) has been shown to 
improve electrode performance by lessening passivation and increasing sensitivity 
(Spegel and others 2007). The Lindau group has worked on an arrangement with a group 
of four microelectrodes that allows for spatiotemporal localization of individual fusion 
pore openings on the surface of a single cell (Dias and others 2002; Hafez and others 
2005). Microfluidic approaches for automated cell targeting and cell trapping have been 
explored (Gao and others 2009; Dittami and others 2010). Chemical and optical methods 
for cell stimulation together with electrochemical and fluorescence detection of 
amperometry have also been demonstrated (Amatore and others 2006; Chen and others 
2008; Meunier and others 2011). 
1.4 Cell-based electrochemical assay of Botulinum Neurotoxin (BoNT) 
BoNTs are produced by the Gram-positive anaerobic soil bacterium Clostridium 
botulinum (Shukla and others 2005). They were first discovered as a contaminant of 
poorly preserved ham in the late 19th century. C. botulinum can grow in soil, spoiled 
food, wounds, and the human intestine. They can also be cultured in large scale in a 
laboratory. Due to the extreme potency, lethality and easy procurement, BoNTs have the 
potential to be very dangerous biological weapons and therefore represent significant 
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warfare and terrorism threat (Arnon and others 2001). BoNTs are one of the 6 category A 
agents listed as the highest risk threat agents for bioterrorism by the US Centers for 
Disease Control and Prevention (CDC) (Centers for Disease Control and Prevention 
2003). Botulinum neurotoxins are potent metalloendoproteases capable of impairing 
transmitter release in neuronal and secretory endocrine cells via targeting and cleaving of 
various SNARE proteins at specific sites thereby inhibiting the process of exocytosis. It is 
a very powerful toxin and can be lethal in very minute doses (median lethal dose (LD50) 
is 1-50 ng/kg of body weight (Band and others 2010)). Apart from being a dangerous 
biohazard agent and a potential weapon of biological warfare, BoNTs are also known for 
their multiple therapeutic uses in conditions such as strabismus, blepharospasms, 
migraine headaches, vocal cord dysfunction, diabetic neuropathy, etc. The most well-
known application of BoNT serotype A is its use as a cosmetic anti-wrinkle agent, known 
commercially as BOTOX®. 
BoNTs are made up of a light chain (LC) metalloprotease catalytic domain (50 
kDa) and a heavy chain (HC), which consists of translocation and binding domains (100 
kDa). After binding and internalization of the toxin via receptor-mediated endocytosis, 
translocation of the LC into the cytosol occurs followed by the final cleavage of SNARE 
complex proteins stage. The seven different serotypes of BoNTs have cleavage 
specificities – while types B, D, F, and G cleave synaptobrevin, types A, C, and E cleave 
SNAP-25, and type C cleaves syntaxin (Čapek and others 2010). Human botulism, 
mainly caused by BoNT/A, /B, /E and occasionally /F can happen through many factors 
like ingestion of contaminated food, wound infections, etc. The symptoms and 
manifestations of botulinum infection are identical for all serotypes and flaccid paralysis 
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occurs within 12 to 48 hours of intoxication. Muscle paralysis starts with facial muscles, 
and continues on to affect shoulders, arms and finally legs. Severe botulism leads to 
paralysis of respiratory muscles and respiratory failure (Kongsaengdao and others 2006). 
Treatment of botulism is mostly based on antitoxin administration in order to bind the 
toxin that has not yet been internalized into cells. Once the toxin enters into the cell, 
however, there is no way of reversing the onset of paralysis. This lack of treatment 
coupled with the extreme toxicity of BoNT makes detection and diagnosis of botulism in 
suspected cases an absolute necessity. Since the toxin plays an important role in 
therapeutic uses as well, it is also of commercial importance to assess the potency of 
BoNT-based products and standardize the assessment before they are approved for 
clinical use. 
The potency of botulinum toxins is currently assessed with a mouse 
intraperitoneal injection assay. It has its inherent shortcomings but it remains the only 
accepted standard test to confirm active BoNTs (Solomon and others 2001). The mouse 
lethality assay has been used for analysis of complex matrices like bacterial cultures, 
serum, fecal, gastric and wound samples. It detects functionally active toxin only and is 
also highly sensitive and specific. However, it is time-consuming, imprecise, laborious, 
expensive, and requires an animal facility as well as the sacrifice of a large number of 
mice. A number of in vitro methods have been developed as alternatives to the mouse 
bioassay. The immunological methods based on binding of an antibody to the toxin are 
easier to perform and significantly faster, but lack in distinguishing between the active 
and inactive forms of the toxin. In vitro assays based on ELISA (Szílagyi and others 
2000; Poli and others 2002; Stanker and others 2008; Volland and others 2008), 
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electrochemiluminescence immunoassay (Gatto-Menking and others 1995; Guglielmo-
Viret and others 2005; Rivera and others 2006; Phillips and others 2008), immuno-PCR 
(Sano and others 1992; Wu and others 2001; Chao and others 2004), fluorescence-based 
biosensors (Ogert and others 1992; Kumar and others 1994; Singh and others 1996; 
Kostov and others 2009), and fluorescence endopeptidase assays (Schmidt and others 
2001; Frisk and others 2009) have also been developed. Cell-based assays of BoNT are 
potentially very sensitive and relevant systems for evaluating toxicity. A FRET based cell 
assay (Dongo and others 2004; Parpura and others 2005), a cell-based assay with 
fluorescence read-out (Thyagarajan and others 2009), and action potentials recorded from 
neural cultures (Scarlatos and others 2008), are some examples of cell-based assays used 
for detection of BoNT. However, these assays are usually less sensitive and slower than 
the mouse in vitro assay. 
1.5 Objectives and Overview 
In an effort to enable high-throughput experiments, our group (Chen and others 
2003; Sun and others 2006; Chen and others 2008; Gao and others 2008; Gao and others 
2009; Sen and others 2009; Barizuddin and others 2010; Liu and others 2011; Yao and 
others 2012) and others are developing microfabricated devices with arrays of 
microelectrodes to measure the release of electroactive transmitter at the single-cell and 
single-vesicle level. These platforms are very different from the usual carbon fiber 
microelectrodes and can be modified to accommodate functionalities that cannot be 
implemented using CFEs. Use of photolithography in microchip fabrication also gives 
better control over electrode fabrication, and enables different electrode materials and 
insulation methods to be tested. Our microchips are ideal for high-throughput studies of 
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quantal exocytosis and have potential applications in drug discovery, assay of toxins like 
BoNT as well as basic science. 
My research projects address two current unexplored areas in electrochemical 
measurement of quantal exocytosis on our lab-on-a-chip platform: the first one is 
developing an electrical method to trigger exocytosis in single chromaffin cells using the 
same underlying electrochemical microelectrode, and the second one is application of our 
microelectrode chip device in assaying toxins like botulinum neurotoxin that affect 
cellular exocytosis. Therefore, in Chapter 3, I focus on investigating the effect of 
transient voltage pulses applied by underlying planar microelectrodes on chromaffin cells 
using whole-cell patch clamp. I found that it is feasible to use an on-chip planar 
microelectrode to electrically stimulate action potentials, the physiological stimuli for 
Ca2+-triggered exocytosis. Voltage pulses ranging from 1.5 V to 3 V lasting for 0.2 ms 
could successfully stimulate action potentials in both chromaffin and INS-1 cells and it 
was shown that they could be stimulated in single chromaffin cells using underlying 
planar electrochemical microelectrodes in an all-or-none fashion. In Chapter 4, I have 
integrated the process of electropermeabilization together with electrochemical 
measurement of neurotransmitter release from single chromaffin cells on the same 
microelectrode. A voltage pulse protocol consisting of 5-6 V (7-train) for duration of 0.1 
ms led to selective permeabilization of an individual cell with precise timing. 
Surprisingly, robust quantal release was elicited upon electroporation in the absence of 
Ca2+ in the bath solution (0 Ca2+/5 mM EGTA). In contrast, electropermeabilization-
induced transmitter release required Cl- in the bath solution in that bracketed experiments 
demonstrated a steep dependence of the rate of electropermeabilization induced 
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transmitter release on [Cl-] between 2 and 32 mM. Finally, in Chapter 5, I present the 
work of assaying the inhibitory effect of botulinum neurotoxin on permeabilized 
chromaffin cells and using on-chip underlying electrochemical microelectrodes to record 
the resulting change in exocytotic frequency via amperometry. Results from comparing 
the rates of secretion in cells that were exposed to the light chain form of BoNT /E toxin 
with those that were exposed to an inactive form of the toxin (Null or RYM) showed that 
there is a modest decrease in secretion rate (P<0.05) in the presence of the active toxin in 
the bath solution. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Preparation of bovine adrenal chromaffin cells 
Chromaffin cell preparation was modified from previously published protocols 
(Ashery and others 1999; Smith 1999) and has been described in details in a paper from 
our group (Yang and others 2007). In brief, fresh bovine adrenal glands were obtained 
from a local slaughterhouse (Davis Meat Processing LLC – Jonesburg, MO). The process 
consisted of isolating the glands from surrounding tissue/fat and keeping them in a Ca2+- 
free and Mg2+-free buffer solution (Buffer 1 solution) at room temperature while 
transporting to the lab. Adherent fat was trimmed from the glands using sterile scissors 
under a sterile culture hood. Blood inside each gland was washed out by injecting Buffer 
1 solution into the opening of the renal vein with a 30 ml sterile syringe and then gently 
massaging the gland to let the solution out. This step was repeated several times until the 
solution coming out of the gland was comparatively clear. Collagenase P was dissolved 
in Buffer 1 solution at a concentration of 1 mg/ml and injected into each gland through 
the opening of the renal vein. The glands were placed in a sterile beaker and put in a 37 
°C shaking water bath for 10 min. Then the glands were taken out, injected again with 
collagenase P and shaken for another 10 min. The collagenase digestion step allows 
isolation of the medulla from the outer cortex tissue. In another sterile Petri dish, the 
gland was cut open along the circumference of the cortex. The digested yellowish/whitish 
medulla was extracted carefully using scissors and put in Buffer 1 solution in another 
Petri dish. The medullae were then thoroughly minced into small pieces using a second 
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set of scissors. The medulla-containing solution was next filtered through a nylon mesh 
(70 μm opening). The filtered solution centrifuged at 140 g/1000 rpm for 10 min at room 
temperature. The supernatant was aspirated and the pellet was resuspended in 18 ml 
Buffer 1 solution. In another tube, percoll gradient solution was mixed with a 10-fold 
concentration Buffer 1 solution (pH = 4.5) at a ratio of 9:1 to make a solution with 
physiological tonicity and a pH of 7.2. The percoll solution was mixed with the cell 
solution at a 1:1 ratio and then centrifuged at 13,000 rpm for 45 min at 18 °C in a high 
speed centrifuge. Following centrifugation, the percoll gradient resulted in 4 layers: dead 
tissue constituting the top layer, norepinephrine and epinephrine secreting chromaffin 
cells in the middle two layers, and red blood cells in the bottom layer. The middle two 
layers were gently pipetted out and transferred to a tube. Buffer 1 solution was added to 
the tube and the cell mixture was centrifuged at 1000 rpm for 10 min. The supernatant 
was removed and the cell pellet was resuspended in Buffer 1 solution. Chromaffin cell 
culture media was added at a 1:3 ratio into the cell suspension to help cells adapt to 
normal Ca2+-containing media. The suspension was centrifuged again at 1000 rpm for 
another 10 min and the supernatant was removed. Following this the cell pellet was 
resuspended in chromaffin cell culture media. Cell density was calculated by adding a 
drop of cell solution onto a hemocytometer. To make it easier to detach cells from the 
flask and to reduce cell clumping we cultured cells in Hibernate A media with calcium 
(BrainBits LLC, Springfield, IL, USA) in a refrigerator (4 °C) and used them 1–6 days 
after preparation. 
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2.2 Design, fabrication and testing of microdevice 
2.2.1 Electrode material deposition 
Device fabrication was carried out using a two-mask photolithographic process. 
Microscope slides (25 × 75 × 1 mm, Fisherbrand, Fisher Scientific, Pittsburgh, PA, USA) 
were used as a transparent substrate and the electrode material of choice was deposited. 
A 110 nm-thick ITO film was sputtered onto the glass substrate using a 
magnetron sputtering system (ATC 2000-V, AJA International Inc. North Scituate, MA, 
USA) with an ITO target (90 wt% In2O3 and 10 wt% SnO2, Williams Advanced Materials 
Inc, Buellton, CA, USA). The parameters for the sputtering process were adapted from 
Deng. et al., (Deng and others 2001). We used DC mode deposition at a power of 100 W, 
a working pressure of 2 mTorr, and a substrate temperature of 325 °C. Ar gas was 
introduced at a flow rate of 20 sccm, and O2 was introduced at 0.2 sccm. The deposition 
time was 600 s. The transmittance spectrum for ITO-coated cover glass was measured 
using a UV-VIS recording spectrophotometer (UV-2401PC, Shimadzu, Kyoto, Japan). 
The conductance of the deposited ITO film was measured using a 4-point probe (S302, 
Lucas Labs, Gilory, CA, USA). 
For the devices with gold as the electrode material, a semi-transparent 30 nm Au 
film was sputtered on top of an adhesion promoting Ti film (10 nm) using an RF 
magnetron sputtering system (ATC 2000-V, AJA international Inc., North Scituate, MA, 
USA, targets obtained from Kurt J. Lesker Company, Clairton, PA, USA). The deposition 
was performed at room temperature with a power of 100 W and a working pressure of 4 
mTorr with an Argon gas flow rate of 20 sccm. The deposition rate for Ti and Au was 2 
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nm/min and 9 nm/min, respectively. The Au film was patterned using photolithography 
and wet etching into 72 conductive traces (36 on each half of the glass slide), 60 μm 
wide, with 2 mm diameter connection pads arranged around the circumference of the 
chip. The Au/Ti coated substrate was first cleaned with 2-propanol, then rinsed with 
deionized water and air-dried. The slide was then cleaned with air plasma at 10.5 W RF 
power level for 1 min (plasma cleaner/sterilizer, PDC-32G, Harrick Scientific Corp., 
Pleasantville, NY, USA). 
DLC:N was deposited on top of transparent indium-tin-oxide (ITO, 15-30 nm 
thick) because the resistivity of DLC:N is high (~1 Ωcm). ITO-coated glass slides were 
obtained by sputter deposition as described above, or purchased from Sigma-Aldrich (St. 
Louis, MO USA) and were cleaned with acetone, methanol, and deionized water. The 
slide was blow dried with air and left on a hot plate for 2 min to remove the moisture. 
DLC:N was subsequently deposited on ITO surface using magnetron sputtering (ATC 
2000-V, AJA international Inc., North Scituate, MA, USA) with 300 Watt DC power, a 
pressure of 2 mTorr, Ar flow of 10 sccm, N2 flow of 10 sccm, and a temperature of 400 
°C. The deposition rate was ~2 nm/min, and film thicknesses of ~40 nm were used for 
transparent electrodes with the microwell approach. The sheet resistance of DLC: N on 
ITO was measured using a four-point probe (S302, Lucas Laboratories, Gilroy, CA, 
USA) and was essentially identical to that of the underlying ITO film (70-100 Ω). 
2.2.2 Electrode patterning and insulation 
Transparent ITO electrodes were patterned on the ITO-coated cover slides using 
photolithography and wet-etching techniques adapted from Sun and Gillis (Sun and 
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others 2006). Briefly, we first rinsed the ITO-coated cover slide with 2-propanol, then 
sonicated for 20 min in acetone (Ultrasonic cleaner 1510, Branson, Danbury, CT, USA), 
then cleaned using air plasma (Plasma cleaner/sterilizer, PDC-32G, Harrick Scientific 
Corp., Pleasentville, NY, USA) for 1 min at the medium RF power level. Shipley S1813 
positive photoresist (Rohm and Haas Electronic Materials, Philadelphia, PA, USA) was 
then spin-coated (single-wafer spin processor, Laurell Technologies Corp., North Wales, 
PA) onto the ITO-coated cover slide at 2500 rpm for 60 s to give a thickness of ~2 μm. 
The coated cover slide was baked on a hot plate at 115 °C for 2 min. Photoresist-covered 
cover slide was exposed to UV light through a high-resolution (20,000 dpi) transparency 
mask (CAD Art Services, Bandon, OR) and then developed in M351 (Rohm and Haas 
Electronic Materials) for ~1 min. It was then baked at 200 °C on the hot plate for 10 min. 
An acidic solution composed of 6 M HCl and 0.2 M FeCl3 was used to wet etch the 
portion of the ITO film that was not protected by photoresist for 30 min, leaving 200 μm-
wide ITO stripes, that widened to form connecting pads on the edge of the chip. The 
photoresist protection layer was then removed with an acetone wash. The cover slide with 
patterned ITO electrodes was rinsed with DD water and air-dried. 
Au electrodes were also patterned by a wet-etch process (Fig 2.1). Shipley S1813 
positive photoresist (Rohm and Haas electronic materials, Philadelphia, PA, USA) was 
spin-coated onto the Au/Ti substrate at 2500 rpm for 1 min resulting in a ~2 μm thick 
layer. The photoresist-covered Au/Ti slide was pre-baked on a hot plate at 115 °C for 2 
min. Then it was exposed to UV light (15 mW/cm2) through a high-resolution (20,000 
dpi) transparency mask (CAD/Art Services Inc., Bandon, OR, USA) (Fig 2.1(a)) and 
developed in diluted M351 (4:1 dilution with deionized water) (MicroChem Corp, 
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Newton, MA, USA) for 1 min (Fig 2.1 (b)). Then the Au/Ti slide was post-baked at 150 
°C on the hot plate for 10 min. Gold etchant solution (Sigma, St. Louis, MO, USA) was 
used for wet-etching the portion of Au/Ti film that was not protected by photoresist for 
~10 s. TFTN solution (Transene Company Inc., Danvers, MA, USA) was then used to 
etch the Ti film at 85 °C for ~20 min. The S1813 photoresist was finally removed using 
PRS-3000 stripper (J.T. Baker, Phillipsburg, NJ, USA) (Fig 2.1(c)). Finally, the patterned 
device was rinsed with deionized water, and dried with compressed air. 
The DLC:N/ITO film was patterned using photolithography and wet etching into 
72 conductive traces (36 on each half of the glass slide), 100 µm wide, with 2 mm 
diameter connection pads arranged around the circumference of the chip. The 
DLC:N/ITO coated substrate was cleaned with 2-propanol, then sonicated for 10 min on 
each side in acetone (Branson Ultrasonic Corporation, model 1510, Danbury, CT, USA), 
and then rinsed with deionized water and air-dried. Finally, the slide was cleaned with air 
plasma at the medium power level for 1 min (plasma cleaner/ sterilizer, PDC-32G, 
Harrick Scientific Corp., Pleasantville, NY, USA). Shipley S1813 positive photoresist 
(Rohm and Haas electronic materials, Philadelphia, PA, USA) was spin-coated (Single-
wafer spin processor, Laurell Technologies Corp., North Wales, PA, USA) onto the 
DLC:N/ITO substrate at 2500 rpm for 1 min resulting in a thickness of ~2 μm. The 
coated DLC:N/ ITO slide was prebaked on a hot plate at 115 °C for 2 min. The 
photoresist-covered DLC:N/ITO slide was exposed with UV light (15 mW/cm2) through 
a high-resolution (20,000 dpi) transparency mask (CAD/Art Services Inc., Bandon, OR, 
USA) and then developed in diluted M351 (M351:H2O = 1:4; Micro-Chem Corp, 
Newton, MA, USA) for 1 min. Following development of the S1813 photoresist, the 
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unprotected DLC:N film was etched with air plasma (PDC-32G, Harrick Scientific Corp., 
Pleasantville, NY, USA) at the High power level for 15 min (40 nm films) or 18 min (120 
nm films). Then, the underlying ITO was wet etched using 0.2 M FeCl3 in 6 M HCl for 
30 min. Subsequently, the S1813 photoresist was removed using PRS-3000 stripper. 
Finally, the patterned device was rinsed with deionized water and dried using compressed 
air. 
We used the thick photoresist SU-8 2025 (MicroChem Corp, Newton, MA, USA) 
both to fabricate microwells and to insulate non-active areas of the conductive film. SU-8 
was spin coated at 4000 rpm for 1 min to yield a film thickness of ~16 μm measured with 
a Tencor Alphastep 200 Profiler (San Jose, CA, USA) (Fig 2.2(a)). It was subsequently 
baked at 65 °C for 3 min and 95 °C for 5 min on hot plates. A second high-resolution 
(20,000 dpi) transparency mask was used to define a single 20 μm diameter microwell / 
electrode opening over each conductive trace as well as openings over each connection 
pad (Fig 2.2(b)). Following mask alignment using a microscope, the photoresist was 
exposed to UV light (11.7 mW /cm2). Then it was post-baked at 65 °C for 1 min and 95 
°C for 5 min on hot plates. It was then developed with SU-8 Developer (MicroChem 
Corp, Newton, MA, USA) for 10 min with mild agitation (Fig 2.2(c)). Finally, the device 
was baked on a hot plate at 150 °C for 2 hrs to seal small cracks on the surface of the SU-
8 film. 
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Fig 2.1 Cross section and top views of Au film patterning using photolithography and wet 
etching. (a) Positive photoresist S1813-covered Au/Ti slide exposed to UV light through a high-
resolution transparency photomask. (b) Au/Ti slide with developed and patterned photoresist. (c)  
The part of Au/Ti film that is not protected by photoresist is wet-etched next using a gold etchant 
solution to pattern it. (d) Top view of patterned gold traces and connecting pads after completion 
of step (c) 
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Fig 2.2 Cross section and top views of insulating patterned Au film (as shown in Fig 2.1) using 
photolithography and wet etching. (a) A negative photoresist (SU-8 2025) is spin-coated on 
patterned Au/Ti electrodes (thickness ~15-16 µm) such that the aspect ratio of the opening (20 
µm diameter) is ~1. (b) Slide is exposed to UV light through a high-resolution transparency 
photomask. (c)  Microwells are patterned on top of electrode traces leaving the non-active areas 
of the conductive film insulated. Also, areas over the bonding pads are defined by developing the 
SU-8 (d) Top view of insulated and patterned gold traces with defined microelectrodes and 
bonding pads after completion of step (c) 
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2.2.3 Microchip assembly 
A 10:1 ratio of polydimethylsiloxane (PDMS) (Sylgard 184, Dow Corning) 
monomer and cross-linking agent was used to make PDMS gaskets for holding the cell-
containing solution on the chip. The monomer was mixed with a curing agent, the 
mixture was degassed in a vacuumed dessicator and then poured into a plastic petri dish. 
After curing for 1 hr in a conventional oven at 80 °C, the PDMS was cut into small 
rectangular slabs with an opening in the middle serving as the PDMS gasket. It was then 
peeled off the petri dish and placed on top of the device to confine the drop of solution 
containing cells to the part on the device where the 36 working electrodes are located 
(Fig 2.3). The assembly was treated with air plasma for 1 min at 10.5 Watts power setting 
to enhance the sealing of the gasket to the chip. This air plasma also helped clean the 
device surface. 
 
Fig 2.3 Top view of an assembled microchip with a PDMS gasket for holding cell-containing 
solution on top of insulated and patterned gold microelectrodes. Also shown is an amplifier 
connection made to a microelectrode via the connection pad and a Ag/AgCl ground/reference 
electrode in the drop of solution confined to the middle part of the chip by the PDMS gasket 
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2.3 Recording action potentials on the microchip 
2.3.1 Electrical stimulation using planar patterned microelectrodes 
Patterned ITO microdevices with 200 µm x 200 µm planar electrodes were used 
for stimulating action potentials in adjacent chromaffin cells. A smaller voltage change 
can be induced in the cell membrane by applying a larger brief voltage step to the 
underlying microelectrode via capacitive coupling. Changes in the cell’s membrane 
potential in turn trigger action potentials in the excitable cells.  Fabricated devices were 
cleaned with 2-propanol, rinsed with deionized water, air-dried and then sterilized via 
exposure to UV light. Finally chromaffin cells were plated and incubated at 37 °C for up 
to a few hours. 
2.3.2 Electrophysiology 
Whole cell patch clamp recordings of membrane potential were made in current-
clamp mode using an EPC9 amplifier (HEKA, Lambrecht, Germany). Patch pipettes 
were fabricated from Kimax glass (Kimax-51, Kimble Glass Inc., Vineland, NJ) using a 
Flaming/Brown micropipette puller (Model P-97, Sutter instrument Co., Novato, CA). 
The pipette resistance typically ranged from 2 MΩ to 5 MΩ when filled with intracellular 
solution and was typically 5 MΩ to 10 MΩ in the whole-cell configuration. Voltage 
pulses were applied to patterned underlying electrodes in order to facilitate transient 
depolarization of the plasma membrane thus inducing action potentials in the chromaffin 
cells. 
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2.3.3 Solutions 
The standard cell bath solution consisted of (in mM): 150 NaCl, 5 KCl, 2 CaCl2, 
1.2 MgCl2, 10 HEPES, and 10 glucose, pH 7.2.The pipette solution used for the whole 
cell patch clamp experiments consisted of (in mM): 150 K-Gluconate, 1 EGTA, 10 
HEPES, 4.6 MgCl2, and 4 Na+-ATP, pH 7.2. 
2.4 Electropermeabilization 
2.4.1 Trypan blue and propidium iodide assays to verify electropermeabilization in 
chromaffin cells 
Electropermeabilization of the plasma membrane of cells was demonstrated by 
staining with trypan blue and propidium iodide. Trypan blue solution (0.4%, Sigma, St. 
Louis, MO, USA) was mixed with regular chromaffin cell medium at a ratio of 1:4. 
Following cell loading, 10–20 ml of this solution was added to 100 ml of cell solution on 
the device. Uptake of dye was evaluated by observing cells under a microscope within 10 
min of staining. Propidium iodide stock solution was made by dissolving 400 µg of 
propidium iodide salt in 1 ml of standard cell bath solution. During experiments, 1 µl of 
propidium iodide stock solution was added to 100 µl of bath solution to attain a final 
concentration of ~4 µg/ml. Uptake of dye was evaluated within 5-10 min of staining and 
electropermeabilization of cells. 
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Fig 2.4 Photos of the device and recording configuration. Connection to the microfabricated 
device is made via the connection pads arranged around the circumference of the chip. The chip 
is mounted on a custom-made holder, which facilitates the connection of the amplifier input to a 
connection pad and insertion of a Ag/AgCl ground/reference electrode in the drop of solution 
confined to the middle part of the chip using the PDMS gasket. The chip plus holder is placed on 
an inverted microscope to observe cell docking to electrodes.  
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2.4.2 Electropermeabilization and subsequent recording of amperometric spikes 
using the same planar patterned microelectrode 
Neurotransmitter release from a single chromaffin cell was induced as well as 
measured by the same planar Au working electrode. Voltage-stimulus protocols were 
adjusted to avoid formation of bubbles at the surface of the electrodes, presumably due to 
hydrolysis of water.  
Voltage pulses led to current being passed through the microelectrode, which 
results in a voltage drop in the electrolytic solution surrounding the cell. This voltage 
gradient led to changes in the cell’s membrane potential that produced electroporation 
upon dielectric breakdown of the cell membrane. For the stimulus-recording electrode 
approach to work, we needed the potentiostat to be capable of supplying a large enough 
current to induce electroporation, yet also be capable of resolving the picoamp-level 
currents associated with amperometric events. This was achieved by having a VA-10 
potentiostat modified in collaboration with the manufacturer, NPI Inc (Tamm, Germany). 
The modification added a diode network in parallel with the op-amp feedback resistor 
such that the diodes “turned on” to bypass the feedback resistor to allow a large transient 
current to be supplied to the electrode in response to a voltage step. Once the capacitive 
current settled the diodes “turned off” to allow low-noise I–V conversion by the feedback 
resistor (Barbour and others 2000). The output of the VA-10 was sampled by the analog-
to-digital converter of the EPC9 amplifier and recorded using Pulse software (HEKA, 
Lambrecht, Germany). During amperometric recording, the VA-10 potentiostat was held 
at a potential of 600 mV relative to an Ag/AgCl wire inserted in the solution that served 
as the counter/reference electrode. Amperometric signals were low-pass filtered with a 
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cut-off frequency of 2.9 kHz and sampled at a rate of 10 ksamples/s. Amperometric 
spikes were analyzed using the software of Segura et al. running on Igor Pro 
(Wavemetrics, Lake Oswego, OR, USA). Spike frequency was counted manually. Spikes 
were not included in the analysis if the peak current was less than 2 pA, had negative 
charges, multiple peaks or other irregular shapes, or 10–90% rise times of greater than 20 
ms. 
2.4.3 Intracellular Ca2+ measurements with Fura-4F 
To load adrenal chromaffin cells with Ca2+ indicator dye Fura-4F AM, hibernate 
media was replaced with loading solution containing 10 μM of Fura-4F AM (stock 25.0 
mM in DMSO). Chromaffin cells in hibernate were taken from a T25 flask, spun down at 
100 g for 5 min, resuspended in 1 ml DMEM and the cell-containing solution was 
transferred to a 15 ml conical tube. After adding 10 μM Fura-4F (AM) and mixing gently, 
the cell suspension was incubated in a humidified incubator (37 ºC, 5% CO2) for 45 min. 
Then the cell suspension was centrifuged at 100 g for 5 min. The supernatant was 
removed with a Pasteur pipette and vacuum, and the pellet was resuspended with 5 ml 
bath solution. The cell suspension was again centrifuged at 100 g for 5 min and the 
supernatant was removed with Pasteur pipette and vacuum. 1 ml bath solution was added 
in and the pellet was resuspended and ready for use. About 50 μl bovine adrenal 
chromaffin cells loaded with Ca2+ indicator dye Fura-4F (AM) were added into the cell 
reservoir on the microchip. After 10 to 20 min, cells would settle onto the DLC/ITO 
microchip surface with some randomly settling directly on top of the working electrodes. 
An inverted fluorescence microscope (IX50, Olympus America) with a 40X 1.15 NA 
water immersion lens (U-APO, Olympus America) was used to observe cells and the 
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transparent DLC/ITO electrodes. A monochromator (Poly II, TLL photonics) and a 
photodiode (TILL Photonics) were used together with the inverted fluorescence 
microscope to measure the fluorescent signal from the Ca2+ indicator dye to report [Ca2+]i 
during the experiment. An EPC-9 amplifier (HEKA) and the corresponding software 
Pulse (HEKA) were used to record the amperometric and fluorescence data. The 
headstage of the EPC-9 amplifier was connected to a connection pad on the edge of the 
chip to activate one of the working electrodes. A Ag/AgCl wire inserted in the cell 
reservoir on the DLC/ITO microchip was used as the ground electrode and connected to 
the ground port on the headstage of EPC-9 amplifier. A 600 mV constant potential was 
applied to a working electrode during experiments. 
2.4.4 Solutions 
The standard cell bath solution consisted of (in mM): 150 NaCl, 5 KCl, 2 CaCl2, 
1.2 MgCl2, 10 HEPES, and 10 glucose, pH 7.2. The Ca2+-free solution was made with 0 
CaCl2 and 5 EGTA. The Na+-free, Ca2+-free solution consisted of (in mM): 135 KCl, 5 
EGTA, 1.2 MgCl2, 10 HEPES, and 10 Glucose, pH 7.2. Similarly, the Cl--free, Ca2+-free 
solution comprised of (in mM): 135 Na-glutamate, 5 EGTA, 1.2 MgCl2, 10 HEPES, and 
10 Glucose, pH 7.2. For the Cl--dependency experiments we used Ca2+-free solutions 
with varied Cl--concentrations by equimolar substitution of Cl- salts with glutamate salts. 
The free Ca2+ concentration in the bath solution was varied using the Ca2+ chelator DPTA 
(diethylenetriaminepentaacetic acid, Kd = 81 µM at pH 7.2 (Smith and others 1987)) 
titrated with Ca acetate rather than CaCl2 to keep the concentration of Cl- fixed. We 
tested electrodes as described previously (Liu and others 2011) by performing cyclic 
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voltammetry with a ferricyanide solution that consisted of 1 mM K3Fe(CN6) in 0.1 M 
KCl, pH 3.0. 
2.5 Using permeabilization to study the effect of Botulinum neurotoxin 
serotype E light chain on chromaffin cell exocytotic machinery 
2.5.1 BoNT wild-type LC/E and inactive LC/E (RYM or Null form) 
Botulinum neurotoxin was obtained in collaboration with Dr. Michael Baldwin 
from the Dept. of Molecular Microbiology and Immunology, University of Missouri. 
Protein expression and purification were carried out as described elsewhere (Baldwin and 
others 2004; Fu and others 2006). BoNT LC/E was constructed by amplifying DNA 
encoding LC fragments from Clostridium botulinum serotype EBegula (Poulet and others 
1992), (E. A. Johnson, University of Wisconsin Madison) and subcloning into pET-15b. 
Plasmids encoding LCs were transformed into Escherichia coli BL21 (DE3) RIL 
(Stratagene) and the cells were cultured overnight on L-agar with 100 µg/ ml ampicillin 
and 50 µg/ml chloramphenicol. Cells were inoculated into LB medium containing 
antibiotics and cultured at 30 °C for 2 h at 250 rpm when cells were induced with 0.75 
mM isopropyl 1-thio-β-D-galactopyranoside (IPTG), and then cultured at 250 rpm 
overnight at 16 °C. Cells were harvested and broken with a French Press in 40 ml of cold 
buffer A (20 mM Tris-HCl (pH 7.9), 1 mM DTT, 10 mM imidazole, and 0.5 M NaCl) 
containing EDTA-free protease inhibitor cocktail (Sigma) and 2.5 µg/ ml DNAse I and 
2.5 µg/mL RNAse I. The lysate was clarified by centrifugation at 20,000g for 20 min at 4 
°C and passed through a 0.45 µm filter. The filtered lysate was applied to Ni-NTA resin 
(5 ml bed volume per 2 l of bacterial culture in buffer A). The column was washed with 
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25 ml of buffer A and eluted with 20 mM Tris-HCl, pH 7.9, containing 250 mM 
imidazole and 0.5 M NaCl. Peak fractions were pooled and subjected to gel-filtration on a 
Sephacryl S200 HR column (150 ml of resin equilibrated in 10 mM Tris-HCl (pH 7.9) 
and 20 mM NaCl). Peak fractions were pooled and subjected to anion exchange 
chromatography (10 ml of resin of DEAE-Sephacel with a 10 mM Tris-HCl (pH 7.9) 
with a 20-500 mM NaCl gradient). Peak fractions were pooled and dialyzed overnight 
into 10 mM Tris-HCl (7.6) and 20 mM NaCl with 40% glycerol (v/v). 
A double mutation in LC/E, R362A/Y365F (RYM), was used to reduce the 
catalytic activity of BoNT to nondetectable levels, while not influence substrate binding 
affinity (Binz and others 2002). The RYM mutant was engineered using Quick Change 
techniques, and purified using the same procedure as the wild-type protein. Purified 
proteins were stored at -20 °C until ready to use. 
2.5.2 Trypan blue assay to verify permeabilization of chromaffin cells in digitonin 
Digitonin-induced permeabilization of the plasma membrane of cells was 
demonstrated by staining cells with trypan blue. Trypan blue solution (0.4%, Sigma, St. 
Louis, MO, USA) was mixed with regular chromaffin cell medium at a ratio of 1:4. 
Following cell loading, 10–20 ml of 20 µM Digitonin solution was added to 30-40 ml of 
a mixture of standard bath and Trypan blue solutions on the device. Uptake of dye was 
evaluated 10 min after staining. 
2.5.3 Digitonin-permeabilization and amperometric recording of quantal exocytosis 
Neurotransmitter release from a single chromaffin cell was induced by incubating 
digitonin-permeabilized cells in a solution containing 14.4 µM Ca2+. Amperometric 
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spikes were measured by the underlying planar Au working electrodes. In order to verify 
that digitonin can effectively permeabilize chromaffin cells, we perfused cells in a 
digitonin-containing external solution using an application pipette and measured 
exocytosis using a planar electrode beneath the cell. 
The BoNT LC/E and the inactive RYM mutant were introduced into 
permeabilized cells by including the proteins in the extracellular solution. Release of 
catecholamines from cells exposed to the wild-type LC/E toxin were compared with 
control cells that were not exposed to the toxin or that were incubated with the inactive 
RYM mutant. 
The amperometric signal was sampled by the analog-to-digital converter of the 
EPC9 amplifier and recorded using Pulse software (HEKA, Lambrecht, Germany). 
During amperometric recording, the EPC9 potentiostat was held at a potential of 600 mV 
relative to an Ag/AgCl wire inserted in the solution that served as the counter/reference 
electrode. Amperometric signals were low-pass filtered with a cut-off frequency of 2.9 
kHz and sampled at a rate of 10 ksamples/s. Amperometric spikes were analyzed using 
the software of Segura et al. running on Igor Pro (Wavemetrics, Lake Oswego, OR, 
USA). Spike frequency was determined manually. 
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2.5.4 Solutions 
The standard BoNT buffer consisted of (in mM): 100 KCl, 45 K-Glutamate, 1.2 
MgCl2, 10 HEPES, pH 7.2. The digitonin-containing buffered Ca2+ solution was 
comprised of (in mM): 125 K-Glutamate, 0.02 Digitonin, 10 HEPES, 1.2 MgCl2, 1.5 
Na+-ATP, pH 7.2. Solutions containing the active toxin or its null form were mixed with 
buffered Ca2+ solution containing digitonin and used in experiments. 
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CHAPTER 3 
ELECTRICAL STIMULATION OF ACTION POTENTIALS FROM 
CHROMAFFIN CELLS USING A PLANAR ELECTROCHEMICAL 
MICROELECTRODE  
3.1 Introduction to approaches used to electrically stimulate excitable cells 
and goal of project 
Action potentials are the physiological stimuli for secretion of hormones and 
neurotransmitters from most neurons and neuroendocrine cells. In neurotransmitter-
secreting cells, opening of voltage-dependent Ca2+ channels, influx of Ca2+ and 
subsequent Ca2+-triggered exocytosis are induced by action potentials. Action potentials 
can be triggered in cells using external stimuli and one widely used approach that is 
employed in neuroscience is to trigger an action potential using a transient electric field. 
Studies on the relationship between action potential stimuli and the resultant exocytosis 
can provide in-depth biological information about cell secretion. For example, the Misler 
group discovered that chromaffin cell secretion has a steeper dependence on the action 
potential frequency than many nerve terminals (Zhou and others 1995). The Artalejo 
group showed that latencies between the onset of action potential stimuli and 
amperometric detection of quantal release of transmitters could be used to infer the 
distance between the L-type Ca2+ channel and the vesicle release sites (Elhamdani and 
others 1998). 
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Patterned electrodes on microchips have also been used to stimulate action 
potentials on adherent cells. The Stett group fabricated a silicon chip for capacitive 
stimulation of action potential (Fromherz and others 1995). The Fromherz group 
developed a semiconductor chip to apply voltage pulses to a neuron that was immobilized 
on the surface of the chip to elicit action potential in the neighboring neuron and the 
action potential was monitored by the underlying chip. Hence, the silicon-neuron-neuron-
silicon circuit was used for presynaptic stimulation and recording, synaptic transmission, 
as well as postsynaptic recording (Zeck and others 2001). To our knowledge, however, 
patterned microelectrodes have not been demonstrated to elicit action potentials in small 
spheroidal neuroendocrine cells like chromaffin cells. 
3.2 Stimulating action potential in single INS-1 and chromaffin cells using 
capacitive coupling on large chip microelectrodes 
We sought to determine experimental conditions whereby action potentials could 
be elicited in an individual chromaffin or INS-1 cell by an adjacent electrochemical 
microelectrode as a method to stimulate, and subsequently record, exocytosis. Fig 3.1(c) 
shows how a smaller voltage change can be induced in the cell membrane potential (Vm) 
by applying a larger brief voltage step (Ve) via capacitive coupling. 
Voltage pulses were applied to 200 µm x 200 µm planar electrodes (Figs 3.1(a) & 
(b)) while simultaneously monitoring the adherent cell’s membrane potential using a 
patch-clamp pipette in the whole-cell current-clamp configuration (Fig 3.1(d)). 
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Fig 3.1 Stimulating action potential in single cells using capacitive coupling on large chip 
microelectrodes. (a) Schematic of 200 µm x 200 µm planar electrodes. Photolithography is used 
to define an opening in the photoresist insulation layer covering the underlying electrode trace. 
(b) The expanded portion on the right shows an individual working electrode with multiple cells. 
(c)  Brief voltage step in Ve evokes a much smaller voltage change in Vm due to voltage divider 
formed from the series combination of the coupling capacitance (Cc) and cell membrane 
capacitance (Cm). (d) Schematic of a cell patch clamped in whole cell mode on a microelectrode. 
Voltage stimulus is applied using the underlying planar electrode and resulting action potentials 
are recorded using the patch pipette. 
Fig 2.3 shows a schematic of a typical chip device with an array of cell-sized Au 
microelectrodes. The working electrode regions are openings in the patterned photoresist 
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insulation layer. A PDMS gasket is designed to hold the solution with cells on top of the 
working electrodes. The schematic in Fig 3.1(c) illustrates a voltage divider circuit 
formed by the series combination of the coupling capacitance (Cc) and cell membrane 
capacitance (Cm). The equation governing the voltage change is: 
∆ ௠ܸ ∆⁄ ௘ܸ = ܥ௖/(ܥ௠ + ܥ௖)                                     Eqn. 3.1 
Fig 3.2(a) below shows a light microscope image of chromaffin cells on an ITO 
electrode and Fig 3.2(b) shows a whole-cell patch clamped single chromaffin cell on the 
electrode. 
 
Fig 3.2 Microscopic images of single/clumped chromaffin cells on 200 µm x 200 µm planar ITO 
electrodes. (a) Light microscope image of an adhered single chromaffin cell. The bluish square 
window represents the use of a suitable wavelength of light (475 nm) from a monochromator in 
order to illuminate the otherwise transparent ITO electrode. (b) A single chromaffin cell on a 
working ITO electrode is whole-cell patch clamped using a patch pipette. 
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First, INS-1 cells as well as chromaffin cells were cultured on ITO electrodes on 
the chip. Single cells were then patch clamped and current was injected into the cell 
through the pipette. The resulting voltage responses (action potentials) were recorded in 
current clamp mode (Fig 3.3) 
 
Fig 3.3 Action potentials resulting from injected current in single (a) INS-1 cell and (b) 
chromaffin cell and recorded using a patch pipette in whole cell current clamp mode 
Once the excitability of the cells was established, INS-1 and chromaffin cells 
were stimulated using transient voltage pulses applied to the electrochemical 
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microelectrode located beneath the cell. Voltage protocols using varying voltage 
amplitudes and durations were tested until optimum voltage ranges were zeroed in on for 
each cell type. Voltage pulses between 1.5 V and 3 V lasting for 0.2 ms were found to 
reproducibly elicit action potentials in both chromaffin and INS-1 cells. 
 
Fig 3.4 Action potentials induced by voltage pulses from underlying planar electrodes in single 
(a) INS-1 cell and (b) chromaffin cell and recorded using a patch pipette in whole cell current 
clamp mode 
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Fig 3.4 shows example traces from (a) a chromaffin and (b) an INS-1 cell where 
individual action potentials are evoked by transient voltage stimulations of 2.4 V/0.2 ms 
and 2.25 V/0.2 ms, respectively.  
In order to induce exocytosis in a cell, a train of action potentials is required, 
therefore I tested protocols with trains of voltage pulses on chromaffin cells. The first 
protocol that was tested consisted of a train of three transient voltage pulses whose 
amplitudes and durations could be varied. Fig 3.5 is a representative trace showing action 
potentials that are induced by one such train consisting of three pulses. 
 
Fig 3.5 Action potential induced by transient voltages, 0.2 ms in duration, applied to the planar 
electrode beneath the pipette.  Arrows indicate transient voltages of 2.4 V, 2.0 V and 2.3 V.  Note 
that action potentials are stimulated in an all-or-none manner with a threshold stimulus between 
2.0 and 2.3 V 
Note that action potentials were induced in an all-or-none manner in that pulses 
with amplitudes of 2.4 or 2.3 V elicited action potentials whereas pulses to 2.0 V failed to 
induce an action potential. We found that the threshold for eliciting action potentials was 
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typically between 2.0 and 3.0 V for chromaffin cells that were well adhered to Au 
electrodes (2.23 ± 0.49 V, 0.2 ms pulse duration, n = 20 cells). Subsequent protocols with 
trains of more than three pulses were used to stimulate single chromaffin cells and 
responses were recorded. However, on repeated stimulation, precipitous drops in cell 
membrane potential resulting from a drop in membrane resistance occurred (Fig 3.6). A 
possible explanation of this phenomenon is that repeated stimulation leads to 
electropermeabilization of the cell membrane. 
 
Fig 3.6 Trains of voltage pulses were applied to chromaffin cells in order to stimulate trains of 
action potentials that are required to induce an appreciable rate of exocytosis. However, a 
precipitous drop in membrane resistance was often observed on repeated stimulation or 
application of higher voltages. The figure denotes an example trace where action potentials were 
induced by transient voltages, 3.1 V in amplitude and 0.2 ms in duration, applied to the planar 
electrode. The abrupt rise in the intracellular voltage after the sixth pulse results from a drop in 
the membrane resistance. 
51 
3.3 Conclusion and discussion 
Our “proof-of-concept” experiments showed that it is feasible to use an on-chip 
planar microelectrode to electrically stimulate action potentials, the physiological stimuli 
for Ca2+-triggered exocytosis. Voltage pulses ranging from 1.5 V to 3 V lasting for 0.2 
ms could successfully stimulate action potentials in both chromaffin and INS-1 cells. 
Using protocols with trains of three voltage pulses up to 2.4 V for a duration of 0.2 ms, it 
was shown that action potentials could be stimulated in single chromaffin cells using 
underlying planar electrochemical microelectrodes in an all-or-none fashion. The abrupt 
drop in membrane resistance that was often observed on repeated stimulation or 
application of higher voltages, however suggested that electropermeabilization of the cell 
membrane is occurring with these types of stimuli. Since electropermeabilization proves 
to be an effective way to induce quantal release from individual cells, we turned our 
attention to optimizing this approach. 
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CHAPTER 4 
ELECTROPERMEABILIZATION OF SINGLE CHROMAFFIN 
CELLS FOLLOWED BY EXOCYTOSIS MEASURED USING THE 
SAME PLANAR ELECTRODE 
4.1 Introduction to the different types of approaches used to stimulate 
exocytosis in neuroendocrine cells and goal of project 
In neurons and endocrine cells, individual secretory granules discharge their 
neurotransmitter content during the process of quantal exocytosis. Although carbon fiber 
amperometry (Wightman and others 1991; Chow and others 1992; Travis and others 
1998; Borges and others 2008) has been extensively used to monitor the time course of 
this catecholamine release, it is a low-throughout process. Recently, in an effort to enable 
high-throughput experiments, our group and others have developed microfabricated 
devices with arrays of microelectrodes to measure the release of electroactive transmitter 
at the single-cell and single-vesicle level (Chen and others 2003; Sun and others 2006; 
Spegel and others 2007; Chen and others 2008; Spegel and others 2008; Barizuddin and 
others 2010; Dittami and others 2010; Liu and others 2011). With existing systems the 
most common way of stimulating exocytosis is by perfusion of cells with a secratogogue 
(Barizuddin and others 2010; Liu and others 2011) leading to depolarization of the cell 
membrane, opening of voltage gated Ca2+-channels, Ca2+ influx and Ca2+-triggered 
exocytosis. Perfusion systems, however, often stimulate multiple cells and do not allow 
precise timing of the stimulus. In contrast, extracellular electrodes can also be used to 
directly depolarize cells and can potentially stimulate individual cells with very precise 
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timing (Fromherz and others 1995; Zeck and others 2001; Dittami and others 2010). 
Significantly, Dittami and Rabbitt demonstrated cells undergo exocytosis when forced 
through a narrow constriction in a microfluidic channel in proximity to a recording 
electrode, perhaps due to cell depolarization. 
Another approach to stimulate exocytosis in neuroendocrine cells is by 
permeabilizing the cell membrane using either high electric fields or chemical agents that 
disrupt the integrity of the cell membrane (Holz 1988; Hay and others 1992). Following 
permeabilization, exocytosis can be elicited by including Ca2+ or other secretagogues in 
the bath solution that subsequently diffuse into the cell. Permeabilizing the plasma 
membrane bypasses the normal excitation pathway and allows one to sort out whether a 
drug or protein mutation affects exocytosis through a direct effect on exocytosis as 
opposed to an effect on the membrane potential mediated by ion channels. It also allows 
one to introduce membrane-impermeable substances into the cell, such as peptides or 
antibodies, to modulate protein function or second-messenger cascades. 
A number of groups have implemented cell electroporation on a microchip, 
usually by applying a high electric field in a microfluidic channel or through a narrow 
aperture (reviewed in (Olofsson and others 2003)). Recently the Orwar group has induced 
electroporation at the single-cell level using carbon-fiber electrodes, thus demonstrating 
the feasibility of electroporation using polarizable microelectrodes suitable for 
electrochemistry (Ryttsen and others 2000). 
We cultured cells on an open-volume microelectrode array and selected electrodes 
with a single adherent cell. We then tested the feasibility of using the same electrode to 
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stimulate a cell and subsequently record release from the cell using amperometry. This 
stimulus-recording electrode approach allows selective stimulation of a single cell, 
measurement of quantal transmitter release within 1 s after permeabilization in order to 
capture rapid kinetic features of exocytosis, and can distinguish quantal release of 
transmitter from vesicles (evident as amperometric spikes) from release of cytosolic 
transmitter or other electroactive compounds (which result in a slowly changing 
background faradaic current) (Cahill and others 1995). A schematic of the approach is 
shown in Fig 4.1. 
4.2 The same electrochemical electrode can be used to stimulate and record 
quantal transmitter release 
The same planar electrochemical electrode was used to stimulate the cell and 
record the electrochemical signal that results from oxidation of released transmitter. Fig 
4.2 depicts a representative trace with amperometric spikes resulting from quantal 
transmitter release induced by electropermeabilization of a single cell on a gold 
microelectrode. 
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Fig 4.1 Schematic of novel stimulus-recording electrode (labeled stimulating electrode and 
recording electrode, respectively) approach where the same electrochemical microelectrode on-
chip is used to electropermeabilize as well as record amperometric spikes from a single 
chromaffin cell 
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Fig 4.2 Trains of voltage pulses result in robust quantal transmitter release. Representative 
amperometric spikes following a train of voltage pulses that permeabilize the cell membrane of a 
single chromaffin cell on a Au microelectrode. The inset (b) is an expanded view of the 
amperometric spikes within the dashed box in part (a) 
The amperometric spikes have amplitudes (Imax), durations (t1/2) and areas (Q) that 
are consistent with previous reports of quantal exocytosis (Table 1 (Wightman and others 
1991; Chow and others 1992; Elhamdani and others 2001; Yang and others 2007)). Thus 
the electrochemical signal that follows stimulating pulses is consistent with quantal 
exocytosis of chromaffin granules. 
Table 1 Mean ± standard deviation of four descriptive spike parameters: half width (t1/2), time to 
peak (tp), charge (Q) and amplitude (Imax). Data obtained from cells electropermeabilized on gold 
microelectrodes in solutions containing a range of chloride concentrations  
t1/2 (ms) tp (ms) Q (pC) Imax (pA) 
1.4±11.5 11.0±2.9 2.2±1.6 64.1±39.5 
# of Cells = 9, # of Spikes = 771 
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A range of stimuli are able to elicit electropermeabilization and quantal release. 
Pulses with durations less than 0.2 ms were used in order to prevent bubbles from 
forming on the surface of electrodes. Individual or trains of voltage pulses from the 
holding potential used for amperometry (~0.6 V) to test potentials of 4–7 V were found to 
trigger massive quantal release from single chromaffin cells. Steps to lower potentials led 
to transient release i.e. secretion that terminated within 10 s of seconds. On the other 
hand, larger voltage steps or pulse trains led to release lasting for minutes. 
 
Fig 4.3 Increasing the amplitude of the stimulus voltage train leads to a greater frequency and 
duration of quantal transmitter release. (a) Representative trace showing infrequent spikes over a 
30 s recording interval when the cell is stimulated by voltage pulse to 3 V (7 pulses, 0.1 ms in 
duration). (b) A subsequent stimulation train to 6 V leads to massive quantal release in the same 
cell that continues for minutes 
58 
Fig 4.3(a) provides a sample response to a train of seven pulses to +3 V, 0.1 ms in 
duration. Note that only a handful of release events are elicited before the response 
terminates. A subsequent train of pulses to +6 V in the same cell elicits a massive 
response (Fig 4.3(b)) that lasts for a number of minutes. Fig 4.4 shows a response from a 
different cell where a train of 7 pulses of 6V amplitude and 0.1 ms duration elicits 
massive release of neurotransmitter lasting for at least 5 minutes. Note that both modest 
and massive stimulation can be useful for studies of exocytosis. Whereas transient 
electropermeabilization could leave the cell more intact to allow probing the cell over 
prolonged intervals, prolonged permeabilization would be necessary to study the 
dependency of exocytosis on external factors like changing concentrations of a molecule 
of interest in the external solution. 
 
Fig 4.4 Massive stimulations of cells may result in thorough electropermeabilization which in 
turn leads to release of neurotransmitter over a prolonged period. Representative trace showing 
robust exocytosis lasting for 5 minutes due to electropermeabilization by a stimulation train to 6 
V 
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The electropermeabilization of the plasma membrane was validated next by 
observing the uptake of membrane-impermeant dyes. Trypan blue is a commonly used 
membrane- impermeant stain that is excluded from viable cells. Since it cannot cross the 
plasma membrane before electropermeabilization, viable cells remained unstained. 
However, following stimulation, permeabilization of the plasma membrane allows the 
dye to enter the cell where it accumulates in the nucleus giving it a blue color. Propidium 
iodide is another known membrane-impermeant nucleic acid stain that is excluded from 
viable cells. However, the increase in membrane permeability that results from 
electroporation allows the dye to enter the cell. Once it enters the cell, the dye binds to 
the nucleic acids and its fluorescence is enhanced 20- to 30-fold. Propidium iodide 
staining indicates that the cell has become receptive to entry of exogenous molecules that 
would otherwise be excluded. 
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Fig 4.5 Uptake of the cell-impermeant dye Trypan blue demonstrates that the stimulation protocol 
leads to selective permeabilization of the cell adjacent to the electrode. (a) Photomicrograph with 
two viable chromaffin cells (encircled) sitting in a standard bath solution containing trypan blue 
before electropermeabilization. The upper cell encircled in green is sitting on the SU-8 insulation 
layer whereas the cell encircled in white is sitting on the working electrode. (b) A few minutes 
after application of the stimulating pulse to the working electrode, the cell sitting on the electrode 
has taken up the dye, indicating electropermeabilization, whereas the green encircled cell not 
directly adjacent to the electrode remains intact. (c) Amperometric spikes resulting from 
electropermeabilization of the cell adjacent to the electrode. 
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Fig 4.5(a) depicts two chromaffin cells; one directly over the electrode (white 
dashed circle) and another cell not adjacent to an electrode (green dashed circle). Neither 
cell took up the trypan blue present in the bath, indicating that they are viable cells. After 
application of the voltage pulse (Fig 4.5(b)), the cell over the electrode takes up the stain, 
indicating electropermeabilization has occurred, whereas the control cell remains 
unstained. This indicates that the stimulation is specific and addressable to the single-cell 
level. Fig 4.5(c) indicates amperometric spikes recorded from the stained cell in Fig 
4.5(b) in response to the voltage pulse and demonstrates that the cell remains viable 
enough to secrete transmitter via quantal exocytosis. Similarly, Fig 4.6(a) depicts a 
chromaffin cell sitting on a working electrode. Fig 4.6(b) is the corresponding 
fluorescence image showing that the cell (yellow dashed circle) did not take up the 
propidium iodide stain present in the bath, indicating a viable cell. After application of 
the voltage pulse (Fig 4.6(c)) to the electrode, the nucleus of the cell is stained red (Fig 
4.6(d)), indicating that electropermeabilization has occurred. Other cells in the vicinity do 
not pick up the dye (data not shown). Fig 4.6(e) shows representative amperometric 
spikes recorded from the stained cell in Fig 4.6(d) in response to stimulation. 
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Fig 4.6 Uptake of the cell-impermeant dye propidium iodide demonstrates that the stimulation 
protocol leads to selective permeabilization of the cell adjacent to the electrode. (a) & (b) Images 
of a viable chromaffin cell (encircled in b) sitting on an electrode in a standard bath solution 
containing propidium iodide before electropermeabilization. (c) & (d) A few minutes after 
application of the stimulating pulse, the cell sitting on the electrode has taken up the dye, 
indicating occurrence of electropermeabilization, (e) Amperometric spikes resulting from 
electropermeabilization of the cell adjacent to the electrode. 
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4.3 Voltage pulses do not degrade the electrochemical electrodes 
The experiments depicted in Figs 4.2–4.6 demonstrate that, following a voltage 
pulse, the electrochemical electrode could recover within several seconds and remain 
sensitive enough to record amperometric spikes with typical features. We next sought to 
determine if the voltage pulses alter the sensitivity of the electrodes or increase 
measurement noise.  
Our experiments indicated no change in the noise (standard deviation) resulting 
from brief (sub ms) pulses to +10 V. In order to test for changes in electrode sensitivity, 
we recorded cyclic voltammograms (CVs) using the test analyte ferricyanide before and 
after applying voltage pulses (Fig 4.7). During the CV the voltage is scanned from +0.7 
V to -0.5 V and a reduction peak is observed at ~+0.1 V as the ferricyanide is reduced to 
ferrocyanide. This reaction is reversed as the voltage is scanned in the positive direction, 
resulting in an oxidation peak. The voltage difference between the oxidation and 
reduction peaks (ΔEp) is a measure of electron-transfer kinetics. Note in Fig 4.7 that 
applying several 0.2 ms pulses to +10 V in between CV measurements has little effect on 
ΔEp or other features of the CVs, therefore there is no apparent degradation of the 
electrochemical sensitivity of the electrode. In fact, ΔEp decreases slightly after 
application of a voltage pulse, perhaps because the voltage pulse oxidizes, and thus 
removes, a thin layer of gold on the surface of the working microelectrode, thus cleaning 
the electrode surface. 
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Fig 4.7 Voltage pulses do not reduce the sensitivity of the electrochemical electrode to a test 
analyte. Cyclic voltammograms were acquired at 1 V s-1 using a 1 mM ferricyanide (K3Fe(CN)6) 
solution in 0.1 M KCl, pH 3. The Au electrode was 20 mm in diameter. In between CVs the 
solution was exchanged to a normal extracellular solution and voltage pulses (+10 V for 0.2 ms) 
were applied 
4.4 Electropermeabilization-induced quantal release is dependent on [Cl-]e, 
but not [Ca2+]e 
Under physiological conditions, exocytosis is triggered in excitable cells by entry 
of Ca2+ into the cell through ion channels. Therefore it would seem likely that 
electropermeabilization of the plasma membrane triggers exocytosis by providing an 
alternative pathway for Ca2+ to enter cells from the extracellular solution. In order to test 
this hypothesis we performed experiments using extracellular solutions with no added 
Ca2+ together with 5 mM of the Ca2+ chelator EGTA to buffer the free Ca2+ concentration 
into the subnanomolar range. Experiments were also carried out using 2 mM BAPTA 
instead of EGTA as the Ca2+ chelator. We were surprised to find that robust exocytosis 
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can be elicited with voltage pulses applied to cells bathed in this “Ca2+-free” solution (Fig 
4.8(a)). In contrast, Ca2+-free solutions do not support substantial exocytosis when 
chromaffin cells undergo large-scale electropermeabilization in a cuvette (Knight and 
others 1982) or are permeabilized with chemical agents such as digitonin (Dunn and 
others 1983). Cell depolarization also fails to elicit exocytosis in Ca2+-free solutions 
(Neher and others 1982). 
 
Fig 4.8 Quantal transmitter release is dependent on the Cl- concentration in the bath. 
Representative experiments from the same cell. (a) A lower spike frequency is observed 
following electropermeabilization in a solution containing 32 mM Cl- (Note that the frequency is 
higher initially but drops gradually with time). (b) Washing with a solution containing 62 mM Cl- 
greatly increases the rate of quantal transmitter release. Changes in Cl- concentration were made 
by equimolar substitution of glutamic acid for Cl- 
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Fig 4.9 Representative experiments from the same cell on Cl--dependency of exocytosis. (a) A 
higher spike frequency is observed following electropermeabilization in a solution containing 62 
mM Cl-. (b) Wash with a solution containing 77 mM Cl- results in a comparable rate of release. 
(c) A final wash with a solution containing only 12 mM Cl- leads to a lower rate of release. 
Changes in Cl- concentration were made by equimolar substitution of glutamic acid for Cl- 
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Fig 4.10 Quantal transmitter release is dependent on the Cl- concentration in the bath. 
Representative bracketed experiment from the same cell. (a) A high spike frequency is observed 
following electropermeabilization in a solution containing 137 mM Cl-. (b) Wash with a solution 
containing 2 mM Cl- greatly reduces the rate of quantal transmitter release. (c) Exchange of the 
bath solution for one containing 32 mM Cl- restores a high rate of transmitter release. Changes in 
Cl- concentration were made by equimolar substitution of glutamic acid for Cl- 
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Whereas extracellular Ca2+ is not essential, we found that mM concentrations of 
Cl- are necessary to support robust quantal transmitter release in response to our 
electropermeabilization protocol. Fig 4.8(a) depicts a sample experiment where 
neurotransmitter release is elicited in a “Ca2+ free” solution containing 32 mM Cl- (with 
equimolar substitution of glutamic acid for Cl-). However, subsequent wash with a 
solution containing a higher Cl- (62 mM) leads to a higher rate of release (Fig 4.8(b)). Fig 
4.9(a) depicts another sample experiment where robust release is elicited in a solution 
containing 62 mM Cl-. Subsequent wash with a solution containing 77 mM Cl- leads to a 
comparable rate of release (Fig 4.9(b)). A final wash with a solution containing only 12 
mM Cl- leads to a lower rate of release (Fig 4.9(c)). Fig 4.10a depicts a third sample 
experiment where robust release is elicited in a solution containing 137 mM Cl-. 
However, subsequent wash with a solution containing only 2 mM Cl- leads to a much 
lower rate of release (Fig 4.10(b)). Subsequent wash with a solution containing 32 mM 
Cl- restores a robust rate of secretion (Fig 4.10(c)). In experiments from 5 cells following 
the same protocol, the rate of quantal release was reduced from 4.1 ± 1.2 to 0.11 ± 0.05 
spikes s-1 upon reduction of Cl- from 137 to 2 mM. Subsequent wash with 32 mM Cl- 
returned the rate of release to 0.53 ± 0.49 spikes s-1.  The lower rate of release at 32 mM 
Cl- compared to 137 mM Cl- (Fig 4.10) may be partially or completely explained by a 
slow “rundown” of exocytosis following electropermeabilization (also see (Knight and 
others 1982)), nevertheless, these bracketed experiments demonstrate a steep dependence 
of the rate of transmitter release on Cl- between 2 and 32 mM using our approach to 
stimulate exocytosis. 
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During exocytosis, vesicles fuse with the cell membrane to release their content 
into the extracellular space. The fusion of a vesicle with the plasma membrane leads to 
transient incorporation of the vesicle membrane with the cell membrane and this leads to 
an increase in the membrane area. This phenomenon can be monitored electrically as an 
increase in surface membrane capacitance (Neher and others 1982). Thus, during whole 
cell patch clamp experiments, introduction of free Ca2+ in the pipette induces exocytosis, 
which in turn results in a membrane capacitance increase. Although 
electropermeabilization-induced exocytosis can occur in the absence of Ca2+, patch clamp 
experiments with chromaffin cells depicted in Fig 4.11 confirm that Ca2+ in the 
intracellular solution is essential to cause increases in membrane capacitance.  
 
Fig 4.11 Ca2+-free, Cl--containing solutions do not elicit massive exocytosis in chromaffin cells. 
Capacitance measurements from whole-cell patch clamp recordings show that buffered 14.4 µM 
Ca2+ in the pipette can elicit exocytosis but absence of Ca2+, even in the presence of 137 mM of 
Cl- does not induce increases in capacitance. In contrast electropermeabilization-induced 
exocytosis leads to robust exocytosis in the presence of 0 Ca2+ and EGTA 
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Thus, in a chromaffin cell, whereas 14.4 µM Ca2+ in the pipette can elicit massive 
neurotransmitter release, Cl- in the absence of Ca2+ fails to elicit exocytosis during whole-
cell patch clamp recording (Fig 4.11).  
A possible explanation for why extracellular Ca2+ is not needed to stimulate 
exocytosis in our experiments is that the pulse protocol leads to release of Ca2+ from 
intracellular stores, either through direct intracellular electroporation, heating, or other 
mechanisms. In order to address this we performed preliminary experiments measuring 
changes in intracellular Ca2+ concentration ([Ca2+]i) in response to voltage pulses. Fig 
4.12(a) presents a sample experiment, representative of three cells, where [Ca2+]i 
increases in response to the voltage pulses when the extracellular solution contains 2 mM 
CaCl2. This is consistent with the hypothesis that electroporation allows substantial influx 
of Ca2+ from the bath solution. An additional two cells, however, did not show a 
prominent [Ca2+]i response, perhaps because the electropermeabilization was transient. In 
contrast, Fig 4.12(b) shows a sample trace, representative of 5 cells, where a voltage 
pulse protocol that reliably evokes exocytosis does not lead to a discernible increase in 
[Ca2+]i if the bath solution contains 0 Ca2+/5 mM EGTA. This suggests that release of 
Ca2+ from internal stores is not prominent under these experimental conditions, although 
we cannot exclude the possibility that spatially local release of Ca2+ occurs that escapes 
detection in our system. 
Whereas the absolute dependence of quantal transmitter release on Ca2+ appears 
to be lost following electropermeabilization under our experimental conditions, we next 
sought to determine if Ca2+ can modulate the rate of Cl--dependent release. We therefore 
set the Cl- concentration to 30 mM, which is a concentration where the rate of release is 
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roughly half maximal in a low Ca2+ solution. Keeping [Cl-]e fixed to 30 mM, cells were 
first electropermeabilized in a 0 Ca2+, 5 mM EGTA solution and then the cells were 
washed with a solution containing 97.7 µM free Ca2+ buffered with DPTA. 
 
Fig 4.12 Release of Ca2+ from internal stores is not prominent under our experimental conditions. 
(a) Denotes an example where the stimulus protocol leads to a clear increase in [Ca2+]i when the 
bath contained 2 mM CaCl2. Similar increases in [Ca2+]i were seen in two other cells, whereas two 
other did not show a clear increases in [Ca2+]i. (b) shows a sample recording where the stimulus 
protocol lead to no discernible increase in [Ca2+]i when the bath solution contained zero added Ca 
and 5 mM EGTA. Similarly, no discernible [Ca2+]i increases were seen in four other cells in 
response to the stimulus protocol 
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Fig 4.13(a) below depicts a sample experiment where neurotransmitter release is 
elicited in an optimum Cl- (32 mM), “Ca2+ free” solution. However, subsequent wash 
with a solution containing a higher Ca2+ shows negligible change in rate of release (Fig 
4.13(b)). Likewise, Fig 4.14(a) depicts a sample experiment where neurotransmitter 
release (at a comparatively lower rate) is elicited in an optimum Cl- (32 mM), “Ca2+ free” 
solution. 
 
Fig 4.13 Ca2+ plays little to no role in modulating the rate of Cl--dependent release in 
electropermeabilized chromaffin cells. (a) A high spike frequency is observed following 
electropermeabilization in a solution containing 32 mM Cl- and 0 Ca2+/EGTA. (b) No significant 
increase in spike frequency is noted on exchange of the bath solution for one containing 32 mM 
Cl- but higher buffered Ca2+ (97 µM) 
However, subsequent wash with a solution containing a higher Ca2+ shows a slight 
decrease in rate of release (Fig 4.14(b)). From (n = 7 cells), the spike frequency was 1.90 
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± 0.42 in the Ca2+-free solution and 1.93 ± 0.50 in the Ca2+-containing solution. Thus, 
surprisingly, Ca2+ is found to play little role in triggering or modulating quantal 
transmitter release when electropermeabilization is induced under our experimental 
conditions. 
 
Fig 4.14 Ca2+ plays little to no role in modulating the rate of Cl--dependent release in 
electropermeabilized chromaffin cells. (a) A low spike frequency is observed following 
electropermeabilization in a solution containing 32 mM Cl- and 0 Ca2+/EGTA. (b) A small 
decrease in spike frequency is noted on exchange of the bath solution for one containing 32 mM 
Cl- but higher buffered Ca2+ (97 µM) 
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4.5 Conclusion and discussion 
As noted previously, the amperometric spikes obtained under Ca2+-free conditions 
have amplitudes and time courses that are typical for exocytosis events from chromaffin 
cells (Table 1). Thus Cl--stimulated, electropermeabilization induced “quantal” 
catecholamine release almost surely occurs from individual chromaffin granules. Our 
experiments cannot resolve, however, whether the release occurs via bona fide exocytosis 
or by lysis of secretory granules as they approach the membrane/electrode surface. 
Of further note is the fact that the dependence of transmitter release on [Cl-]e 
occurs after the electroporation step since manipulation of [Cl-]e after electroporation 
modulates the rate of ongoing transmitter release in a reversible manner (Fig 4.10). We 
speculate that the dependence of vesicle release on Cl- may be mediated by ClC Cl- 
channels on the vesicle membrane (Maritzen and others 2008). It is interesting to note 
that Cl--containing solutions have previously been reported to support lysis of secretory 
granules isolated from chromaffin cells (Holz 1986). 
We have developed an approach where the same electrochemical electrode 
located immediately below a cell can be used to stimulate and record quantal release of 
catecholamines from an individual chromaffin cell via electroporation. The voltage-pulse 
protocol leads to selective permeabilization of an individual cell with precise timing. 
Mild stimuli support reversible electroporation, which may in the future allow 
transfection of cells to express proteins of interest followed by on-chip measurement of 
exocytosis from transfected cells.  
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CHAPTER 5 
CELL-BASED DETECTION OF BONT LC/E IN PERMEABILIZED 
CHROMAFFIN CELLS USING ON-CHIP ELECTROCHEMICAL 
MEASUREMENT OF QUANTAL EXOCYTOSIS  
5.1 Introduction to existing methods for detection of botulinum neurotoxin 
(BoNT) 
Botulinum neurotoxins (BoNTs) are one of the most toxic substances known to 
human. With a median lethal dose (LD50) of 1-50 ng/kg of body weight (Band and others 
2010), they are the cause of botulism, a life-threatening neuroparalytic disorder (Dembek 
and others 2007). BoNT intoxication is marked by flaccid paralysis originating from an 
inhibition of neurotransmitter release from motor neurons. On a molecular level, BoNTs 
impair transmitter release in cells by cleaving several isoforms of the three SNARE 
proteins that are critical for vesicle fusion with the plasma membrane (Schiavo and others 
2000). 
BoNTs are produced by the gram positive anaerobic soil bacterium Clostridium 
botulinum (Shukla and others 2005). Strains of C. botulinum are classified into seven 
types, A to G, according to the antigenic properties of BoNTs they produce. These are 
large proteins with a molecular weight of 150 kDa. After synthesis, the BoNT complexes 
remain relatively inactive (Cai and others 2007) until they are activated by protease 
nicking to form a dichain molecule made up of a light chain (LC) and a heavy chain (HC) 
linked by a single disulfide bond and many other non-covalent interactions between the 
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two peptide chains. (Singh 2000). The LCs are zinc-endopeptidases, which cleave 
specific proteins involved in vesicle docking and fusion, whereas, the HCs play an 
accessory role by helping in cell binding and translocation through the plasma membrane 
and into the cytosol (Li and others 1999; Simpson 2004; Montecucco and others 2005; 
Singh 2006). Fig 5.1 shows how neurotransmitter release occurs at a neuromascular 
junction and how the light chain of BoNT disrupts the vesicle fusion process by cleaving 
the SNARE proteins. 
Each of the 7 different serotypes cleaves a unique peptide bond located on one of 
the SNARE proteins (Schiavo and others 1992; Blasi and others 1993; Breidenbach and 
others 2004). BoNT/A and /E cleave synaptosomal associated protein of 25 kDa (SNAP-
25), at positions 197–198, and 180–181, respectively. Human botulism is caused mainly 
by BoNT/A, /B, /E and occasionally /F. However, the duration of induced muscle 
paralysis varies from one serotype to the other. Muscle paralysis caused by BoNT/A can 
last for several months while BoNT/E has been observed to have relatively short-lived 
effects (Eleopra and others 1998). Although it is known that BoNTs are a dangerous 
biohazard agent capable of causing widespread casualties, these toxins are used in 
important therapeutic applications. A  wide variety of conditions including cervical 
dystonia, strabismus, blepharospasms, hemifacial spasms, hyperhidrosis, myofacial pain, 
migraine headaches, vocal cord dysfunction, diabetic neuropathy, anal fissure and 
multiple sclerosis are treated using BoNT toxin products. Additionally, the most well-
known application of BoNT serotype A is its use as a cosmetic anti-wrinkle agent, known 
commercially as BOTOX® (Fig 5.2). 
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Fig 5.1 Neurotransmitter release at a neuromascular junction and cleaving of SNARE proteins by 
light chain of BoNT resulting in disruption of the vesicle fusion process. Acetylcholine in nerve 
terminals is packaged in vesicles. Normally, vesicle membranes fuse with those of the nerve 
terminals, releasing the transmitter into the synaptic cleft. The process is mediated by a series of 
proteins collectively called the SNARE proteins. Botulinum toxin, taken up into vesicles, cleaves 
the SNARE proteins, preventing assembly of the fusion complex and thus blocking the release of 
acetylcholine. (Reproduced with permission from (Rowland 2002), Copyright Massachusetts 
Medical Society) 
The high toxicity of BoNTs makes the detection of the toxin and diagnosis of 
botulism a matter of great challenge. Due to the extremely low lethal dose of the toxin, it 
is also difficult to induce host responses detectable for diagnostics. The mouse lethality 
assay currently remains the only accepted standard test to confirm active BoNTs 
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(Benedetto 1999). On introduction of dilutions of BoNT samples in mice via 
intraperitoneal injections, specific botulism symptoms that finally lead to death are 
observed. The test is based on monitoring the mice for 48 hrs at each stage of analysis 
after injection of toxin. With subsequent dilutions of the sample, the maximum dilution 
that kills the mice as well as the minimum dilution that does not kill are estimated 
(Benedetto 1999). These are then used to approximate the quantity of BoNT in the 
sample by relating the maximum dilution which kills to the known mouse lethal dose 
(MLD50, 10 pg for BONT/A) (Ferreira 2001). 
 
Fig 5.2 BoNT, if administered locally and in therapeutically safe doses, can be of cosmetic as 
well as therapeutic help. The picture above shows use of BOTOX® that is injected under the skin 
to remove wrinkles from the forehead region 
The toxicity of BOTOX® is also expressed in a unit of bioactivity or potency 
called the biologic mouse units (U). The median lethal dose or the amount of toxin 
needed to kill 50% (LD50) of a group of female Swiss Webster mice that weigh 18-22 g 
each, constitutes one mouse unit. The human LD50 is 40 U/kg or about 2500 – 3000 U 
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for a 70-kg person. However, for cosmetic purposes, the usual total dose of BOTOX® 
that is administered during any treatment session is less than 100 U. This being about 3% 
of the human LD50, accidental overdosing resulting in poisoning is highly unlikely to 
happen. In fact, no case of systematic toxicity due to accidental injection or ingestion of 
BOTOX® has ever been reported (Benedetto 1999). The LD50 assay does not allow for 
standardization of potency units for products made by different manufacturers because of 
the inherent variability in conducting the assay and species differences in sensitivity to 
the various toxins. This poses problems in product use and has potential safety 
consequences which are magnified as new products enter the market. Dramatic 
differences in the apparent potency confound clinical dose finding and could potentially 
result in over or under dosing of patients. Developing a technology that can resolve issues 
of standardization and address variability using a high-throughput system is the key to 
bettering the prospects of an in vitro cell-based BoNT assay. 
Over the years, several new methods for detection of BoNT have been developed 
to overcome the limitations of the mouse bioassay. The majority of these alternative in 
vitro assays are immunological methods based on binding of an antibody to the toxin. 
Starting with radioimmunology assays, through passive hemagglutination and 
immunodiffusion assays, more recently the more sensitive Enzyme-Linked 
Immunosorbent Assays (ELISA) have been adapted for detection of BoNT. Using 
specific antibody binding to the toxin, ELISA has proved to be the most commonly 
employed method for in vitro detection of all serotypes of BoNT (Čapek and others 
2010). The remarkable cleavage specificity of BoNTs has enabled the widespread 
development of activity assays. Alongside ELISA-based assays developed for detecting 
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BoNT proteolysis, several methods have been successfully used for separation of BoNT 
cleavage products from the substrates to assay for toxin activity (Hakami and others 
2010). Higher throughput speed can be achieved by automation of the process steps but 
this comes at the cost of sensitivity (Čapek and others 2010). An assay which has 
significant benefits over ELISA is the fluorescent sandwich immunoassay that can be 
performed on beads with more complex and expensive flow cytometry instrumentation 
used to detect and quantify the toxin (Čapek and others 2010). Another variation is the 
highly-sensitive Immuno-PCR which is an ELISA-type immunoassay that uses PCR for 
exponential amplification of the ELISA signal (Sano and others 1992). Easier and 
simpler to use assays like the hand-held immunochromatographic assay work based on a 
capture antibody-analyte-detection antibody interaction. They generate simple visual 
read-outs but have reduced detection limits (Čapek and others 2010). Systems using 
cross-flow immunochromatographic method and ganglioside-liposomes as detection 
agent show improved sensitivity (Ahn-Yoon and others 2004). Though robust and 
sensitive, immunological in vitro assays are incapable of discriminating between the 
active and inactive forms of BoNT and hence cannot be used in assays meant for 
detection of active toxin forms in clinical preparations. Endopeptidase activity based 
assays, like the mouse assay, can detect only active toxin species. High-throughput 
fluorescence endopeptidase (Frisk and others 2009) or fluorescence resonance energy 
transfer (FRET) technology-based assays are used for the detection of cleavage of peptide 
bonds. Some of these assays also have high sensitivity (Čapek and others 2010). 
Immunology (Ekong and others 1997) and mass spectrometry (Boyer and others 2005) 
are also used for detection of SNARE cleavage products. However, the critical problem 
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with enzymatic assays is that they are not very robust. In complex milieus, interference 
can lead to reduced sensitivity necessitating the need to immunoseparate the toxin. In the 
last decade, microchip technology has been widely adopted in assays for BoNT for 
relative advantages like reduced reagent consumption and semi-automated nature of 
operation, among others. 
The few cell based BoNT assays like the fluorescent read-out assays (Thyagarajan 
and others 2009) or the assays based on changes in action potentials in neurons exposed 
to toxin (Scarlatos and others 2008), can be especially valuable as diagnostics, as they 
can recapitulate the natural environment in which analytes like BoNT cleave SNARE 
proteins to inhibit neurotransmitter secretion. However, these are usually less sensitive 
and require days to be executed due to time taken for cell culture and detection. 
5.2 Introduction of Botulinum neurotoxin Light Chain /E (BoNT LC/E) into 
chromaffin cells 
Currently there is no BoNT assay that is high-throughput, sensitive, easy-to-use as 
well as capable of differentiating the active toxin species from the inactive one. Our 
system offers a unique solution as it combines high-throughput with detection of active 
toxin. Although at present the assay is not very sensitive, there is the potential to make it 
more sensitive in the future, and overall, it provides for a robust platform to assay the 
effects of BoNT on cellular neurotransmitter secretion. The chip device boasts of an 
uncomplicated design capable of performing the basic tasks of cell targeting/handling and 
recording with ease. On the microchip platform, instead of manipulating an electrode 
precisely to touch the cell, the cell is targeted to individual working electrodes. The 
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simplicity of the design also ensures that the cell is not subjected to any other mechanical 
stimuli (like movement or flow as in a microfluidic channel), which might give us 
spurious results. The most conspicuous advantage of the system is that once the toxin is 
introduced into the cell, the native environment is provided for the protein to target and 
cleave the SNARE complex on the cell membrane, which has the potential to make the 
assay more sensitive than an in vitro assay. Our cell of choice is the chromaffin cell 
because they exhibit robust neurotransmitter secretion and are readily available. Our lab-
on-chip device allows simultaneous targeting of dozens of cells on one device at any 
given time. Using specialized surface chemistry modifications, up to 70% cell targeting 
to individual electrodes can be achieved (Liu and others 2011). Each cell measurement 
typically only takes 2-5 min. Multi-channel amplifiers, being built and tested in our lab, 
can help in recording from multiple cells at once thus increasing the throughput. 
The novel aspect of this approach is the use of the same on-chip microelectrode 
on which the chromaffin cell is permeabilized to record the resulting exocytosis response 
from. The working electrode records picoamp (pA) level currents from the oxidation of 
catecholamines as they are released from individual granules. 
BoNTs are synthesized and released by the Clostridia as inactive ~150 kDa 
protein precursors. Activation requires proteolytic cleavage that generates disulfide-
linked di-chain toxins made up of the ~100 kDa heavy chain which is involved in the 
translocation of the 50 kDa light chain (Singh 2000; Cai and others 2007). Utilization of 
the holotoxin in experiments is constrained due to its intrinsic toxicity and the need to 
activate the holotoxin, which can cause an error in the analysis of catalytic activity. These 
difficulties can be overcome by generating recombinant, catalytically active but 
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inherently non-toxic light chain proteins that allow more detailed structure–function 
studies of BoNT (Baldwin and others 2004). The crystal structures of BoNT/A (Lacy and 
others 1998), BoNT/B (Swaminathan and others 2000), and BoNT/E (Kumaran and 
others 2009), along with all BoNT (Hanson and others 2000; Agarwal and others 2004; 
Segelke and others 2004; Agarwal and others 2005; Arndt and others 2005; Arndt and 
others 2006) and TeNT light chains (Breidenbach and others 2005), have been 
determined. Overall, the LC structures are similar and provide a basis for comparative 
functional studies (Fu and others 2006). The rationale behind using BoNT LC/E as the 
model toxin to study effects on exocytosis is that LC/E induces a more thorough 
inhibition of neurotransmitter secretion since it dissociates SNAP-25 from syntaxin by 
cleaving a larger amino acid fragment of SNAP-25 i.e., BoNT LC/E has the specific 
advantage in vitro of completely abrogating vesicle fusion. In comparison, BoNT/A 
cleaves a shorter fragment, only partially blocking vesicle fusion, and SNAP-25 retains 
its interaction with plasma membrane syntaxin. 
BoNTs specifically bind to peripheral nerve endings at the neuromuscular 
junction via the 50 kDa C-terminal half of the 100 kDa HC (the HC-fragment). Neuronal 
cell membranes consist of binding sites that are particularly composed of complex 
polysialogangliosides, glycosphingolipids, etc. When BoNT is externally administered to 
chromaffin cells, however, very little inhibition of neurotransmitter release occurs 
because chromaffin cells contain only small amounts of gangliosides and the neurotoxin 
or its light chain subunit must gain direct access to the interior of the chromaffin cell in 
order to inhibit secretion. Preincubation of intact chromaffin cells with gangliosides leads 
to incorporation of the glycolipids into the cell membrane, thereby facilitating entry of 
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the toxin (Marxen and others 1991). BoNTs are known to bind mainly to gangliosides of 
type GT1b (Kitamura and others 1980) and GD1a (Habermann and others 1985). 
Primary chromaffin cells used in our experiments are isolated from bovine 
adrenal glands (Yang and others 2007). As mentioned earlier, these cells are candidates 
for assaying effects of BoNT for two principal reasons. First, they exhibit healthy 
secretion of catecholamines and are, in fact, the most widely used cell type for 
electrochemical studies of quantal exocytosis. They have large dense granules that enable 
biophysical studies of vesicles and individual fusion kinetics. Classical methods like 
carbon fiber amperometry have shown how these cells can be adopted as good model 
systems for studying the process of exocytosis. The other important aspect is that all 
BoNT serotypes can affect and cause widespread inhibition of neurotransmitter secretion 
from these specialized cells (Penner and others 1986). However, the downside is that 
chromaffin cells do not have the necessary cell membrane receptors to aid in uptake of 
BoNT (Marxen and others 1989). We plan to render cells permeable to the toxin by using 
i) electropermeabilization and ii) permeabilization using the well-known detergent 
digitonin. 
5.3 Introduction of BoNT via electropermeabilization on-chip 
As described in chapter 4, the same planar electrochemical microelectrode was 
used to stimulate the cell and record amperometric spikes that result from oxidation of 
released transmitter. Individual or trains of voltage pulses from the holding potential used 
for amperometry (~0.6 V) to test potentials of 6 V were found to trigger massive quantal 
release from single chromaffin cells. Since massive release indicates thorough poration of 
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cell membrane, a train of seven pulses to +6 V was used as the standard 
electropermeabilization protocol. Fig 5.3 below gives us a schematic representation of 
our single-cell electropermeabilization approach used to introduce BoNT into chromaffin 
cells on-chip. A single chromaffin cell sitting on a working electrode in a BoNT buffer 
solution containing BoNT LC/E is electropermeabilized by application of a voltage 
stimulus to the underlying electrode. Permeabilization of the plasma membrane leads to 
entry of BoNT LC/E from the bath solution. SNAP-25 is cleaved and when a second 
stimulating pulse is applied, inhibition of exocytosis can be observed from the drop in 
spike frequency. 
Figs 5.4 and 5.5 provide sample responses to introduction of the BoNT LC/E 
neurotoxin via electroporation of the cell membrane using a train of seven pulses to +6 V, 
0.1 ms in duration. Amperometric recordings in Figs 5.4(a) and 5.5(a) are from single 
representative cells during introduction of the toxin. Since electropermeabilization is 
partial we need to allow the electroporated cell to sit in the BoNT solution for a few 
minutes. This allows time for diffusion of the BoNT LC/E toxin inside the cell from the 
external solution. Hence appreciable deactivation of the exocytotic machinery can be 
expected. The initial neurotransmitter release reflects none to very low inhibition. 
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Fig 5.3 Schematic of single-cell electropermeabilization to introduce BoNT on-chip approach. 
First, a single chromaffin cell sitting on a working electrode in a BoNT buffer solution containing 
BoNT LC/E is electropermeabilized using voltage stimulation to the underlying electrode. The 
electropermeabilized cell allows entry of BoNT LC/E (similar to Fig 4.1). (a) Introduced BoNT 
LC/E cleaves SNAP-25 in the cell and when a second stimulating pulse is applied, (b) zero to few 
amperometric spikes are recorded from the cell showing that exocytosis has been inhibited 
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Fig 5.4 Introduction of BoNT LC/E in chromaffin cells via electropermeabilization and its effect 
on quantal exocytosis. (a) A high spike frequency is observed immediately after 
electropermeabilization in a solution containing 102 mM Cl- and 2.9 µM BoNT LC/E. (b) A drop 
in frequency is noted on 2nd electropermeabilization after 31 minutes 
Figs 5.4(b) and 5.5(b) show representative spikes from the respective cells after 
waiting periods of 31 and 23 minutes, respectively. While Fig 5.4(b) shows an 
appreciable drop in spike frequency, Fig 5.5(b) shows no change from before and after 
introduction of the toxin. Both occurrences were seen frequently in electropermeabilized 
chromaffin cells and data was pooled from 11 cells to study the inhibitory effect of BoNT 
LC/E. 8 cells showed a decrease in number of spikes from 200+ to <50 in 1 min 
recordings, whereas 3 cells showed a consistent secretion of ~100+ spikes (in 1 min) 
from before and after introduction of the toxin. 
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Fig 5.5 Introduction of BoNT LC/E in chromaffin cells via electropermeabilization and its effect 
on quantal exocytosis (contd.). (a) A high spike frequency is observed immediately after 
electropermeabilization in a solution containing 102 mM Cl- and 2.9 µM BoNT LC/E. (b) 
However, unlike in the previous example, no drop in spike frequency is noted on 2nd 
electropermeabilization step after 23 minutes 
It can be noted here that initially the waiting time between the first and the second 
electropermeabilizing pulses was kept to 5-10 minutes. However, no appreciable decrease 
in spike frequency was noted. Hoping to have better diffusion of the toxin inside the 
electropermeabilized cells, the waiting time was increased to 20-30 minutes. 
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Fig 5.6 Control experiment to show that rundown due to prolonged exocytosis can occur in 
electropermeabilized chromaffin cells. (a) A high spike frequency is observed following 
electropermeabilization in a solution containing 102 mM Cl- and 0 µM BoNT LC/E. (b) 
Although, there is a no toxin in the bath solution, a significant drop in spike frequency is noted on 
2nd electropermeabilization after 21 min 
Control experiments were performed to verify that the decrease in spike 
frequency in cells could primarily be attributed to the inhibitory action of the toxin on the 
neurotransmitter secretion machinery, and not just rundown due to the waiting period and 
prolonged exocytosis. These experiments consisted of electropermeabilizing cells in the 
absence of BoNT LC/E. Representative cells (3) showed an average decrease in 
exocytotic frequency from 200+ to <50 in 1 min recordings (Fig 5.6) as opposed to 2 that 
showed a consistent secretion of ~100+ spikes (in 1 min) from the first 
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electropermeabilization step to the second, proving that rundown may occur in cells over 
a period of time. In order to attempt to reduce rundown, cells were electroporated using 
milder voltage pulse protocols. Instead of the 6V/0.1 ms (7-train) pulses, 5V/0.1 ms (7-
train) pulses were used since it has been shown previously that comparatively small 
voltage pulses lead to transient electroporation of chromaffin cells. However, 
representative experiments (4) showed that no appreciable change was observed in spike 
frequency in cells that were transiently electropermeabilized in the presence of BoNT 
LC/E toxin (data not shown). 
Data obtained from experiments suggests that use of electropermeabilization to 
introduce BoNT LC/E into cells is not a robust method as reflected by absence of 
effective and reproducible inhibition of neurotransmitter secretion. Also, we hypothesize 
that electropermeabilization occurs on only a portion of the plasma membrane and hence, 
permeabilizing chromaffin cells more thoroughly could yield better results. Another 
important factor is that electropermeabilization-induced exocytosis is dependent on [Cl-]e. 
This Cl--dependency paired with the absence of Ca2+ in the BoNT buffer solution might 
also affect BoNT-induced inhibition of quantal exocytosis in electropermeabilized 
chromaffin cells. 
5.4 Introduction of BoNT via digitonin-induced permeabilization of cells 
As we have seen previously, electropermeabilization can be used to render 
chromaffin cells permeable to exogenous molecules. Similarly, low concentrations of the 
detergent digitonin can be efficiently used for permeabilization and ions like Ca2+ as well 
as larger molecules like proteins can be introduced inside cells (Fiskum and others 1980). 
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Increase of permeability in plasma membrane of digitonin-treated chromaffin cells can 
elicit exocytosis and release catecholamines upon addition of micromolar Ca2+ to the 
extracellular solution (Dunn and others 1983). Electrochemical detection of exocytosis of 
individual chromaffin granules from digitonin-permeabilized cells has been done using 
carbon fiber electrodes (Jankowski and others 1992). Introduction of BoNT toxin inside 
chromaffin cells via digitonin-incubation or transfection has been shown to inhibit 
exocytosis and has been assayed using carbon fiber amperometry (Gil 1998; Graham and 
others 2000). 
Chromaffin cells are digitonin-permeabilized in the presence of the 50 kDa BoNT 
light chains in order to allow the toxin to diffuse into the cell and cleave the SNARE 
proteins associated with secretory vesicle fusion thus causing inhibition of 
neurotransmitter secretion. The schematic of the process is similar to that in Fig 5.3, the 
only difference being that digitonin-permeabilization is used instead of 
electropermeabilization. To look for effects on exocytosis, 5-10 min after the 
permeabilized cells are exposed to the toxin in the presence of micromolar amounts of 
[Ca2+]i, the cells are amperometrically probed. A catalytic null mutant of the toxin 
(RYM) is used in control experiments in order to determine if only the active toxin can 
affect exocytosis in exposed cells. In humans, BoNTs have a median lethal dose (LD50) 
of ~1-50 ng/kg (6.67 fM-0.33 nM) (Band and others 2010) of body weight. In whole-cell 
patch clamp experiments, ~400 nM of BoNT LC/E (Xu and others 1998) has been found 
to completely block exocytosis while in digitonin-permeabilized chromaffin cells, a 
maximal inhibition of 55% occurs at 310 nM neurotoxin (Bittner and others 1989). My 
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preliminary experiments were carried out using a solution containing 1–4 µM of BoNT 
LC/E. 
Digitonin is a steroid glycoside which, used as a detergent, can effectively water-
solubilize lipids. Hence it has found widespread use in permeabilizing cell membranes 
(Dunn and others 1983; TerBush and others 1988; Holz and others 1989; Tengholm and 
others 2000). In order to introduce BoNT via membrane poration, chromaffin cells are 
incubated in 8-20 µM digitonin mixed with a solution containing an active form of the 
light chain toxin and buffered micromolar Ca2+. 
Chromaffin cells are first assayed for efficiency of digitonin permeabilization. 
They are either exposed to 8-20 μM digitonin and 5-14.4 μM free Ca2+-containing cell 
bath solution, or a pipette containing digitonin is brought close to the cell suspended in 
Ca2+-containing external solution. The content of the pipette is perfused onto the cell by 
applying gentle pressure. Free Ca2+ diffuses into the cell through the permeabilized cell 
membrane and triggers quantal catecholamine release, which is detected by the 
underlying on-chip planar electrochemical microelectrode. 24 out of 36 cells exposed to 
20 μM digitonin and 14.4 μM free Ca2+-containing external solution showed robust 
exocytosis whereas 25 out of 28 cells that were exposed to 14.4 μM free Ca2+ only 
showed none to negligible neurotransmitter secretion. Representative traces of 
amperometric spikes from both experiments can be seen in Fig 5.7. From these 
preliminary results, we expect digitonin to permeabilize cells more thoroughly and 
irreversibly, and going forward, we have used this method in our experiments. 
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Fig 5.7 Robust quantal exocytosis in cell permeabilized by digitonin and bathed in 14.4 µM free 
Ca2+. (a) Control cell shows few spikes when exposed to Ca2+ only. (b) Cell permeabilized by 20 
µM digitonin shows robust exocytosis in the presence of free Ca2+ 
Next, we employed trypan blue staining and on-chip amperometry to verify the 
permeabilizing ability of 10 µM digitonin on chromaffin cells. Cells are exposed to a bath 
solution containing 14.4 μM free Ca2+ and imaged using a light microscope. Exposing 
non-permeabilized chromaffin cells to Trypan blue shows low to minimum staining since 
intact cell membrane of viable cells is impermeable to the stain (data not shown). 
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Fig 5.8 Uptake of the cell-impermeant dye Trypan blue demonstrates that digitonin induces 
efficient permeabilization of cells. Photomicrograph with permeabilized chromaffin cells sitting 
in a standard bath solution stained by trypan blue. The cell encircled in white is sitting on a 
working Au electrode. 
In the first step, digitonin containing bath solution was added to cells on the chip. 
After letting the cells incubate in digitonin for a few min, Trypan blue solution was 
added. The cells were allowed to sit for a few more min before they were photographed. 
Cells are stained blue due to entrance of the dye inside the cell through the permeabilized 
cell membrane where it accumulates in the nucleus giving it a blue color. Fig 5.8 depicts 
chromaffin cells on-chip with one cell sitting directly over the electrode (white dashed 
circle). After a brief exposure of permeabilized cells to a trypan blue solution, ~100% of 
cells picked up the dye indicating that digitonin can uniformly and thoroughly 
permeabilize a population of chromaffin cells. 
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Once the permeabilization protocol was in place, light chain BoNT/E toxin in 
buffer was used in the external solution in order to assay its effect on exocytosis. In the 
first set of experiments some permeabilized cells are exposed to the toxin while others 
from the same batch are assayed in a toxin-free solution. After loading on the device, 
chromaffin cells are suspended in 1.5 µM BoNT LC/E in 10 µM digitonin-containing 
BoNT buffer solution and ~7.2 μM free Ca2+-containing external solution. 8 cells were 
analyzed to obtain a total of 605 spikes giving an average secretion rate ± standard 
deviation of 0.63 ± 0.12 events/sec. Example traces are shown in Fig 5.9 (a) and (b). In 
contrast, data obtained from 6 cells assayed in ~13.9 μM free Ca2+-containing external 
solution mixed with 10 µM digitonin showed that 1505 spikes were recorded making it at 
an average rate ± standard deviation of 2.07 ± 0.66 events/sec (sample traces shows in 
Fig 5.9 (c) and (d)). Digitonin-permeabilized cells exposed to the light chain of BoNT/E 
showed a 69.56% inhibition in the rate of secretion (not taking into account the increase 
in free Ca2+-concentration from the cells exposed to the toxin to the control cells). 
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Fig 5.9 Appreciable amount of inhibition in exocytosis is seen in digitonin-permeabilized cells 
when they are exposed to 1.5 µM BoNT LC/E whereas digitonin-permeabilized cells in control 
experiments exposed to a buffered Ca2+ solution show vigorous exocytosis. (a) Representative 
trace showing how the frequency of amperometric spikes falls to zero on exposure to 1.5 µM 
toxin along with 10 µM digitonin and 7.2 µM Ca2+. (b) A second representative trace showing 
consistent low spike frequency in a digitonin-permeabilized cell in a similar solution. (c) 
Representative trace showing uniform frequency of amperometric spikes in a control cell in 10 
µM digitonin and 13.9 µM Ca2+. (d) A second representative trace showing a gradual increase in 
spike frequency in a digitonin-permeabilized cell in the presence of 13.9 µM buffered Ca2+ 
As a control we used an inactive form of the BoNT LC/E protein (RYM). The 
first set of experiments compared the responses from permeabilized cells exposed to 
either the RYM mutant or controls unexposed to protein. 13 cells assayed in 7.8-13 µM 
RYM LC/E in 8-20 µM digitonin-containing BoNT buffer solution together with ~14.4 
μM free Ca2+-containing external solution were analyzed to obtain a total of 1727 spikes 
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giving an average secretion rate of ± standard deviation of 1.11 ± 0.38 events/sec (sample 
traces shown in Fig 5.10 (a) and (b)).  
 
Fig 5.10 No appreciable inhibition in exocytosis is seen in digitonin-permeabilized cells when 
they are exposed to ~7.8-13 µM RYM. This is comparable to control experiments with digitonin-
permeabilized cells exposed to buffered Ca2+. (a) Representative trace showing 13 µM of the null 
toxin (RYM) in the presence of 20 µM Digitonin and 14.4 µM Ca2+ does not affect the frequency 
of amperometric spikes. (b) A second representative trace showing consistent high spike 
frequency in a 8 µM digitonin-permeabilized cell in the presence of 7.8 µM RYM and 5.8 µM 
Ca2+ in the bath. (c) Representative trace showing uniform high frequency of amperometric spikes 
in a target cell bathed in 20 µM Digitonin and 13.9 µM Ca2+ only (d) A second representative 
trace showing a lower but consistent spike frequency in a digitonin-permeabilized cell in a similar 
solution as in (c) 
On the other hand, another 13 cells from the same batch assayed in ~5.76-13.9 
μM free Ca2+-containing external solution mixed with 8-20 µM digitonin were analyzed 
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to obtain a total of 1398 spikes giving an average secretion rate ± standard deviation of 
0.9 ± 0.21 events/sec (representative traces shown in Fig 5.10 (c) and (d)). Therefore, not 
taking into account the variation in Ca2+-concentration in the bath solution, the 
experiments showed that the RYM mutant does not have an effect on exocytosis. 
The principle control experiment is done to compare the secretion rates of cells 
exposed to the light chain BoNT/E toxin versus the RYM inactive mutant. On being 
exposed to a solution with a mixture of the 1.6 µM RYM protein, 10 µM digitonin and 
14.4 μM free Ca2+, 1159 events were recorded from 8 cells (representative traces shown 
in Figs 5.11 (a) and (b)). 8 others cells from the same batch, when exposed to 1.5 µM 
BoNT LC/E along with 10 µM digitonin and 14.4 μM free Ca2+, showed a drop in 
secretion such that a total of 773 events were manually counted (sample traces shown in 
Figs 5.11 (c) and (d)). The average rate ± standard deviation from the null protein and the 
BoNT were calculated to be 1.2 ± 0.12 and 0.8 ± 0.12 events/sec, respectively. Thus the 
active BoNT LC/E resulted in a 33% decrease in the rate of exocytosis compared to the 
RYM mutant. Table 2 below lists all the different combinations of solutions that were 
used to determine the effect of the active BoNT LC/E toxin on exocytosis as opposed to a 
control which is either toxin-free (digitonin and Ca2+ only) or contains an inactive form 
of the toxin (RYM). The results suggest that the digitonin-permeabilization method can 
be used to assay the effect of BoNT LC/E on the exocytotic machinery of chromaffin 
cells. T-tests were performed on all three data sets. For the BoNT LC/E vs. BoNT LC/E 
Null (RYM), our t-test showed a difference in the rate of neurotransmitter secretion in the 
presence of the toxin when compared to the rate of neurotransmitter secretion in the 
presence of the inactive form of the toxin (P=0.035 i.e. P<0.05). 
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Fig 5.11 No appreciable inhibition in exocytosis is seen in digitonin-permeabilized cells when 
they are exposed to 1.6 µM RYM as opposed to cells that show inhibition when they are exposed 
to 1.5 µM BoNT LC/E. (a) Representative trace showing how the RYM doesn’t affect the 
frequency of amperometric spikes. (b) A second representative trace showing consistent low 
spike frequency in a digitonin-permeabilized cell in the presence of 1.6 µM RYM, 10 µM 
Digitonin and 14.4 µM Ca2+ in the bath. (c) Representative trace showing how the frequency of 
amperometric spikes is very low after exposure to 1.5 µM BoNT LC/E, 10 µM Digitonin and 
14.4 µM Ca2+. (d) A second trace showing consistent low spike frequency in a digitonin-
permeabilized cell in the presence of 1.5 µM BoNT LC/E in the bath 
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Table 2 Mean ± standard deviation of secretion rates observed in digitonin-permeabilized cells 
exposed to BoNT LC/E, its Null form RYM or a toxin-free bath solution. Also shown are the 
respective percentage changes in spike frequency in different sets of experiments. Data obtained 
from cells permeabilized on gold microelectrodes in solutions containing 5.76-14.4 µM Ca2+. 
 BoNT LC/E BoNT LC/E Null (RYM) Toxin-free 
BoNT LC/E vs. Toxin-free 
# of Spikes 
605 
(# of cells = 8) 
 
1505 
(# of cells = 6) 
Rate 
(spikes/sec) 
0.63±0.12  2.07±0.66 
Percentage Change = (2.07-0.63)/2.07 = 69.56% 
BoNT LC/E Null (RYM) vs. Toxin-free 
# of Spikes  
1727 
(# of cells = 13) 
1398 
(# of cells = 13) 
Rate 
(spikes/sec)  1.11±0.38 0.90±0.21 
Percentage Change = (0.90-1.11)/0.9 = -23.33% 
BoNT LC/E vs. BoNT LC/E Null (RYM) 
# of Spikes 
773 
(# of cells = 8) 
1159 
(# of cells = 8) 
 
Rate 
(spikes/sec) 0.80±0.12 1.20±0.12 
 
 
Percentage Change = (1.2-0.8)/1.2 = 33.33% 
 
5.5 Conclusion and discussion 
We have already seen that electropermeabilization induced “quantal” 
catecholamine release is the result of formation of transient pores on the plasma 
membrane followed by diffusion of exogenous molecules inside the cell. Here we first 
tested the efficiency of electropermeabilization in introducing the light chain of BoNT/E 
101 
in single chromaffin cells. Due to various factors like the local nature of 
electropermeabilization and the plausible size and function of BoNT LC/Es as opposed to 
ions like Cl-, it was found that this process was not a very efficient one. Another popular 
permeabilizing agent, digitonin was used to replace electropermeabilization in assaying 
BoNT LC/E. Cells were permeabilized in digitonin while being simultaneously exposed 
to micromolar amounts of the active or the null form of the toxin along with micromolar 
amount of Ca2+. Results show that the rate of neurotransmitter secretion in the presence 
of BoNT LC/E when compared to the rate of neurotransmitter secretion in the presence of 
the inactive form i.e., BoNT LC/E Null (RYM), are statistically different (P<0.05). 
Like other cell-based assays, our single-cell assay based on high-throughput 
electrochemical detection of quantal exocytosis is valuable as diagnostics since it 
provides a natural environment in which light chains of BoNT can cleave SNARE 
proteins to inhibit neurotransmitter secretion. However, though the method seems to be a 
robust one, it is currently not highly sensitive and takes 1-3 days to complete taking into 
account time taken for cell culture, detection on-chip and analysis of results. It can be 
noted that in this approach, specifically timing a stimulus is not of utmost importance and 
there is no requirement to porate the cells transiently in order to keep them viable over a 
long period of time. In fact, using multi-channel amplifiers developed by Exocytronics 
LLC can greatly increase the throughput of our assay. Also, since the new amplifier and 
headstage designed by Exocytronics comes with the option of simultaneously using 240 
electrodes per chip via a multiplexing approach, a larger number of cells from the same 
batch can be simultaneously assayed on the same device under different experimental 
conditions. 
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CHAPTER 6 
CONCLUSIONS AND FUTURE DIRECTIONS 
6.1 Conclusions 
The theme of this study is the development and application of electrical methods 
to stimulate and subsequently record quantal exocytosis from single chromaffin cells on 
microfabricated chips. 
Some of the most widely prevalent techniques that are used to stimulate 
exocytosis in chromaffin cells on chips are perfusion methods that stimulate the whole 
population of cells on a chip. Cells are perfused with a secratogogue, leading to 
depolarization of the cell membrane. Prime examples are depolarization by a high K+-
solution, or application of extracellular Ba2+, or the Ca2+ ionophore ionomycin. However, 
given our chip design, a perfusion system not only stimulates multiple cells but also does 
not allow precise timing of the stimulus. Photorelease of caged Ca2+ can be used to 
address individual chromaffin cells and stimulate them precisely, but this requires an 
elaborate optical setup. Electrical stimulation can elicit action potentials in excitable cells 
and a train of action potentials can lead to stimulation of exocytosis. So we started this 
project by using our microchip planar electrochemical microelectrodes to elicit action 
potentials in single chromaffin cells. Action potentials were elicited in an all-or-none 
fashion. However, on repeated stimulation, permeabilization of the membrane occurred. 
Since permeabilization methods have been shown to be effective ways to induce quantal 
neurotransmitter release from chromaffin cells, we turned our attention to optimizing this 
approach. 
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Cells could be electropermeabilized on-chip and following a voltage pulse, the 
electrochemical electrode was found to recover within several seconds and remain 
sensitive enough to record amperometric spikes of pA level currents and other typical 
features. Cyclic voltammograms with ferricyanide solution demonstrated that short 
voltage pulses of up to 10 V for 0.2 ms duration did not degrade the thin electrochemical 
electrodes and the same chip and same electrode could be reused for multiple recordings. 
Several combinations of amplitude and duration of voltage pulses were tested and a range 
of stimuli was found to elicit electropermeabilization and quantal release. Whereas steps 
to lower potentials led to transient release, larger voltage steps or pulse trains led to 
release lasting for longer periods. Individual cells on microelectrodes were also stained 
using membrane-impermeant dyes like trypan blue and propidium iodide to show that 
voltage pulses can electropermeabilize cells and still leave them physiologically intact for 
neurotransmitter secretion. 
A surprising finding from these experiments was that robust exocytosis could be 
elicited with voltage pulses applied to cells bathed in “Ca2+-free” solution. Ca2+-free 
solutions, however, do not support substantial exocytosis when chromaffin cells are 
permeabilized or depolarized using other methods. Whereas extracellular Ca2+ is not 
essential, mM concentrations of Cl- was found to be necessary to support robust quantal 
transmitter release in response to our electropermeabilization protocol. Bracketed 
experiments demonstrated that not only is Cl- important for electropermeabilization-
induced exocytosis, but also there is a steep dependency of the rate of transmitter release 
on Cl- between 2 and 32 mM. Neither did I see any evidence that Ca2+ modulated the rate 
of release nor evidence of release of Ca2+ from internal stores upon electroporation.  
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Further studies are needed to clarify the role of Cl- and to determine if ClC Cl- channels 
in vesicles contribute to electroporation-induced exocytosis. 
Botulinum neurotoxins are potent metalloendoproteases capable of impairing 
transmitter release via targeting and cleaving of various SNARE proteins at specific sites 
and their extreme toxicity makes it necessary for the toxin to be detected in a given 
sample with high sensitivity and selectivity. The mouse intraperitoneal assay remains the 
gold standard but it is important to develop cell-based assays of BoNT that can replace 
the mouse lethality assay in detecting active toxin in a sample. Once 
electropermeabilization was established to be an effective method in stimulating 
exocytosis in single cells on-chip, we used our platform to develop an in vitro cell-based 
high-throughput assay to quantify BoNT. Cells were electropermeabilized in the presence 
of the light chain of BoNT/E. After electropermeabilization of the cells in the presence of 
the LC/E, cells were allowed to sit in the solution for a few minutes and amperometric 
spikes were recorded before and after introduction of the toxin to assay its effect. We 
hypothesized that our electroporation method leads to local electroporation of the cell 
membrane and we documented negligible difference in spike frequency upon 
electropermeabilization with BoNT LC/E in the external bath. The extent of cell-
electroporation depends on various factors including cell-size, proximity of the cell 
surface to its underlying electrode, extent of cell adhesion to the electrode, etc. Due to 
these varied conditions, it became difficult to predict with precision the length of time 
that would be sufficient for the toxin to diffuse inside the cell as well as the extent of 
perfusion of the toxin inside the cell after electropermeabilization. Hence we increased 
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the waiting time between the electroporation and amperometry steps. This however led to 
the complication of run-down of exocytosis even in cells not exposed to the toxin.  
Next we chose to use a detergent called digitonin to permeabilize cells on our 
device following previous studies.  The permeabilization of the plasma membrane was 
validated by studying the uptake of the membrane-impermeant stain Trypan blue. Paired 
experiments were performed comparing the amount of exocytosis observed when 
incubating cells in either BoNT LC/E or an inactive BoNT LC/E mutant at a 
concentration of ~1.5 µM in the presence of digitonin and buffered Ca2+. Although the 
BoNT null mutant experiments didn’t show any dramatic decrease in spike frequency, 
some amount of inhibition of exocytosis was seen in digitonin-permeabilized cells 
exposed to the light chain /E. The percentage decrease was statistically significant 
(P<0.05) and the platform seems to hold potential in detecting the presence of µM 
amount of BoNT LC/E in a given sample. 
6.2 Discussion and possible future directions 
6.2.1 Electropermeabilization-induced Cl--dependent exocytosis 
Exocytosis triggered by electropermeabilization of single chromaffin cells needs 
to be explored further in order to determine the mechanisms whereby it triggers release. It 
would be useful to carry out further studies using fluorescent Ca2+ indicators to more 
carefully examine possible release of Ca2+ from internal stores or to track exocytosis 
from fluorescently labeled vesicles. However, the Au electrodes used in our device are 
almost opaque and not suitable for fluorescent studies. Popular electrode materials 
including ITO, which is highly transparent, and DLC:N on ITO, which is comparatively 
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more translucent, can be tested for electropermeabilization efficiency using our protocols. 
However, in preliminary experiments I was not able to reliably induce exocytosis by 
applying voltage pulses to electrodes fabricated from ITO. But a set of successful 
amperometric recordings were made on DLC:N on ITO chips (data not shown). Future 
experiments testing different pulse protocols may give us more definitive results on both 
materials. 
In electropermeabilization-induced Cl--triggered exocytosis, the [Cl-]e-
dependency of transmitter release seems to be independent of the electroporation step 
since manipulation of [Cl-]e after electroporation can modulate the rate of ongoing 
transmitter release in a reversible manner. Ca2+ is observed to play little role in triggering 
or modulating quantal transmitter release when electropermeabilization is induced under 
our experimental conditions. The anion selective channel Cl250 was rarely observed in 
chromaffin granules and its activity could be observed only in the presence of calcium in 
the medium (Hordejuk and others 2006). The hypothesis that the dependence of vesicle 
release on Cl- may be mediated by ClC Cl- channels on the vesicle membrane (Maritzen 
and others 2008) can be tested by carrying out electropermeabilization-induced 
amperometric recordings from chromaffin cells isolated from ClC-3 knock-out mice. 
Capacitance measurements and amperometry showed that exocytosis of large dense-core 
vesicles (LDCVs) was decreased in chromaffin cells from ClC-3 knock-out mice. 
However, immunohistochemistry complemented with subcellular fractionation showed 
that ClC-3 is not detectable on LDCVs of endocrine cells and are localized to endosomes 
and synaptic-like microvesicles. Thus, it is thought that ClC-3 channels, though not found 
on large dense-core vesicles involved with exocytosis in chromaffin cells, indirectly 
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influence LDCV exocytosis possibly by affecting an intracellular trafficking step  
(Maritzen and others 2008). Known Cl- channel blockers like 5-nitro-2-(3-
phenylpropylamino)-benzoic acid (NPPB) (Pothos and others 2002) can also be used to 
test the hypothesis that Cl- channels are involved in Cl--dependent exocytosis upon 
electroporation.  Another approach is to test which anions (e.g., I-, F-, SO42-) can 
substitute for Cl- in supporting exocytosis and compare this selectivity with the known 
permeation sequence of Cl- channels. 
Another generic application of single-cell electropermeabilization and subsequent 
electrical or fluorescent measurement on-chip could be in the vast field of transfection. 
Electroporating single cells on top of electrodes with reproducible geometry, as opposed 
to electropermeabilizing a population of cells in a cuvette, may induce less cell damage 
and be more consistent between cells.  It would also require less preparation than 
developing viral transduction vectors. The efficiency of this proposed application could 
be tested by using our platform to electrotransfect chromaffin cells with a fluorescent 
protein like GFP and comparing it to other existing techniques like the Semliki Forest 
virus (SFV) gene expression system (Ashery and others 1999) or electroporation in a 
cuvette. 
6.2.2 Cell-based assay for detection of BoNT 
Our cell-based assay for the detection of Botulinum neurotoxin, while being 
robust and capable of high-throughput, needs considerable optimization in order to detect 
lower concentrations of the toxin for it to have a similar performance as the mouse 
bioassay. It is possible that sensitivity is lost upon loss of soluble cell components during 
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permeabilization with digitonin.  Ideally, permeabilization would not be necessary to test 
the holotoxin, but chromaffin cells do not effectively take up the toxin presumably 
because they do not have the ganglioside receptors for the HC.  A possible approach 
would be to engineer a cell to serve as a sensitive biosensing element to interface with 
our electrochemical electrode arrays.  The ideal cell would have the receptor gangliosides 
found in motor neurons but would secrete catecholamines so that exocytosis could be 
readily detected with an electrochemical electrode. 
Another improvement to increase throughput would be to use multichannel 
amplifiers, such as those being developed by Exocytronics LLC, in order to record from 
multiple cells simultaneously. 
Using both electropermeabilization and digitonin-permeabilization in conjunction 
with amperometric recording from multiple cells on our biochip, a broad spectrum of 
high-throughput single-cell experiments can be conducted. For example, we can test 
drugs that target exocytosis such as reserpine, a vesicular monoamine transport blocker 
that decreases quantal size, or l-dopa, a catecholamine precursor that increases quantal 
size, to different cell lines or primary cells in order to do massive screenings of their 
effect on neurotransmitter release. This can help elucidate the basic mechanism of cell-to-
cell communication and potentially benefit health-related research. 
Solution exchange on our chips during permeabilization experiments is an 
important aspect and manual exchange of solutions using pipetters can be clumsy and 
potentially dislodge cells from their electrode wells. To achieve easier solution exchange 
and perfusion, microfluidic channels could be integrated into the microdevice. Using 
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microfluidics for solution exchange could make the process gentler, easier and faster 
thereby increasing the throughput of our experiments. 
Another aspect of electropermeabilization or digitonin-permeabilization of cells 
on our multielectrode array device is that cell debris can easily foul the electrode, 
decrease its sensitivity, and prevent further reuse of the fabricated device – especially 
since the electrodes are cell-sized, they are more difficult to clean. We propose the use of 
Tergazyme (Alconox, NY USA), an enzyme-activated powdered detergent for laboratory, 
healthcare and industrial applications. Its protease enzyme removes proteinaceous soils, 
tissue, blood and body fluids (Alconox), and devices can either be soaked or 
ultrasonicated in the solution for proper cleaning. 
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